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ABSTRACT 
The I blood group system in humans was investigated in 
order to study cell surface changes in development. 
One advantage in studying the I-antigen in man is the 
availability of well defined, easily purifiable cold agglu-
tinin molecules with anti-I specificity. Sera from patients 
with chronic cold agglutinin, post pneumonia cold agglutinin 
and post viral influenza cold agglutinin di.sease have been 
studied. The IgM agglutinins were isolated and their restric-
ted heterogeneity established. These well characterized 
protein molecules were used in experiments to study the I 
antigen's development and in experiments designed to reveal 
information about the molecular basis of I antigen specif i-
city. 
The development of I antigen and postnatal changes in 
hemoglobin were examined in human infants, to see whether the 
developmental changes in these two attributes are correlated 
in mdividual cells in such a way as to suggest that they have 
common biochemical control mechanisms. The results demon-
strated that the expression of I antigen on the erythrocyte 
surf ace is independent from the control mechanism of the 
biosynthesis of the beta chain of hemoglobin. These observa-
tions are explained by suggesting two separate modulatory 
regulations, one for the enzymes involved in the expression 
of I-specific molecules on the cell surf ace and another for 
the regulation of hemoglobin subunit synthesis. 
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The rates of A-antigen and I antigen site development 
were compared using I 125 labeled anti- A IgG molecules in order 
to test for possible common control or close association. 
Erythrocytes from postnatal inf ants were fractionated with 
respect to their I-agglutinability. Experimental results 
indicate that cells with well expressed I-specificity have 
more A-antigen sites; less sites were found on erythrocytes 
with weak expression of I antigen . These results suggest that 
enzymes responsible for the expression of these two antigenic 
specificities are under a common control mechanism or that 
they are closely associated. 
Erythrocyte stromata from human adults and from umbilical 
cord blood samples were fractionated. Fingerprints of the 
two membrane preparations indicated that the major protein 
components are identical. Molecular fractionation of the 
stomata resulted in fractions with I antigen activity. All 
fractions with I-activity contained ABO blood activity, but 
some preparations with ABO activity failed to inhibit agglu-
tinins with I-specificity . Hydrophilic fractions containing 
glycopeptides with blood group activity were isolated. The 
I-activity was pronase sensitive. Quantitation of molecular 
fractions with I blood group activity from cord and adult 
erythrocytes suggests that I-negative phenotype could be 
explained by either the two dimensional distribution of 
molecules on the cell surface or by the covering up of the 
I-specific molecules in the membrane . 
vi 
The significance of these findings are discussed with 
respect to embryonic cell surface specificity and with 
respect to the recognition of molecular patterns by IgM 
molecules with multiple binding sites . 
vii 
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INTRODUCTION 
Human blood group antigens 
Man's age-old desire to perform blood transfusion as 
a treatment for various diseases, to expel evil spirits and 
for rejuvenation led to the foundation of immunohematology. 
It became a pioneering field to study specific molecules on 
cell surfaces and their recognition by circulating antibodies. 
There are no precise records on the first attempts of 
blood transfusion, but descriptions from the early seven-
teenth century already indicated the possibility of trans-
ferring blood from one individual to another. In 1615, 
Andreas Libavius wrote about "the rejuvenation of an ·old 
and thin, emaciated man with the blood of a robust young 
man full of spirited blood (l)". One of the earliest 
reports on the results of transfusing unmatched blood came 
from Jean Denys in 1667 (2). Nine ounces of blood was 
transfused from a lamb into the vein of a young man 
suffering from "leutic madness". Although the technique 
was successful, the patient passed urine as black as soot. 
Incompatability of the red blood cells resulted in comple-
ment mediated lysis and release of hemoglobin. Subsequent 
publications were predominantly empirical observations 
until KarlLandsteiner's systematic study of red cell agglu-
tination at the turn of this century. He was the first to 
point out that there are antigenic differences among the 
2 . 
red blood cells of people. The recognition of the ABO blood 
groups was followed by the development of safe blood trans-
fusion. In 1910 van Dungern and Hirszfeld suggested the 
Mendelian inheritance of these groups (4), but it was not 
until the 1920's that the current interpretation of ABO as 
dependentona multiple-allelic series was established. 
Subsequent years led to the discovery of additional blood 
group antigen systems in man. Today at least eleven we+l 
established systems are known with the possibility of dis-
covering more. These systems are the ABO, MNSs, P, Rh, 
Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt and I (5). 
The antigens of these systems are expressed on the surf ace of 
erythrocytes. Some of them also appear on other cells or on 
secreted molecules of the body fluids. 
It seems ironical that after fifty years of experience 
in matching blood groups prior to transfusion, organ trans-
plantations were performed in the 1950's and early l960's 
without sufficient matching of the antigens controlled by 
.the histocompatability locus. These antigens are expressed 
on lymphocytes and on the surfaces of cells in vital organs. 
Organ rejection occurs if the donors and recipients are 
mismatched (6). 
The molecular structure of cellular antigens was first 
studied by inhibition techniques. Monosaccharides and oligo-
saccharides with known composition were tested for their 
capacity to inhibit antisera against blood group antigens. 
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A second approach consisted of chemical and enzymatic modif i-
cation of the cell surf ace and examining the effect of such 
treatment on agglutinability of the cells. Research on the 
molecular basis of antigenic specificity benefited greatly 
from the observation that secreted mucopolysaccharides also 
possess blood group specificity. Most of the biochemical 
work was carried out on this material, because it is available 
in large quantities from saliva, gastric mucin, or ovarian 
cyst fluid. These efforts lead to the establishment of the 
terminal sugar sequences in polysaccharide chains of glyco-
proteins which confer A,B and H specificity (7), as summar-
ized on Figure 1. 
A-specific chains terminate with an N-acetyl-galactos-
amine residue and B-specific chains with a galactose residue. 
The oligosaccharide chains in group 0 individuals end with 
~-L-fucosyl-(1-2)-galactose, which also serves as the point 
of addition for the A and B-specific residues. This chain 
has the H-specificity. Glycotransferase enzymes, necessary 
for the biosynthesis of the A and B terminal carbohydrate 
sequences, are controlled by the ABO locus. d.-N-acetyl-D-
galactosaminyltransferase, which transfers N-acetyl-D-
galactosamine from uridine diphosphate N-acetyl-D-galactos-
amine to the acceptor oligosaccharide with H specificity, has 
been shown to occur in submaxillary glands from group A or 
group AB individuals, but not from group B or group O indi-
viduals (8). Similarly the enzyme o<-D-galactosyltransfer-
ase has been shown to occur in submaxillary glands and in 
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Type 1 chains 
'A' sp~cificity 
a-GalNAc-(1-.3)-p-Gal-(t-3)-GNAc-
fi.2 
a-Fuc 
'B' specificity 
a-Gal-(1-3)-p-Gal-(1-3)-GNAc -
~.2 
a-Fuc 
'H' sp~cificity 
CH,OH CK,OH 
~trtr~, 
0 
s 
OH 
P-Gal-(1-3)-GNAc-
ju 
a-Fuc 
Type 2 cha ins 
Cq''°", 0 
. OH NHC;:, O OH NHCOCH
1 
0 
e 
OH 
Cl-GalNAc-{1-3l·p-Gal-(1 ... 4)-GNAc-
i1,2 
Cl-Fuc 
~\ ·qCH,OH  T-o\._ 
~o- o~OCH, 
~~ 
b~ 
OH 
a-Gal-(1-.3l-P ·Gal-(1-+4)-GNAc -
tt,2 
a-Fuc 
P-Gal-(1-4)-GNAc-
11.2 
a-Fuc 
Figure 1. Terminal sugar sequences which confer A,B and H 
specificity on polysaccharide side chains of 
glycoproteins. The abbreviations used are: 
Fuc: L-fucopyranosyl; Gal: D-galactopyranosyl; 
GNAc: N-acetyl-D-glucosaminopyranosyl; GalNAc; 
N-acetyl-D-galactosaminopyranosyl. (A~ter 
Watkins ( 7)). 
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gastric mucosal material from group B and AB individuals. 
This enzyme transfers D-galactose from uridine diphosphate 
galactose to the terminal nonreducing end of the H-active 
structure (9). Very little is known about the structure of 
these enzymes and they have not yet been isolated from 
erythrocytes. Because the two substrates are almost iden-
tical (the only difference is between an OH and an N-acetyl 
amino group),point mutation or a limited amino acid substi-
tution have been suggested to explain the differences in 
specificity. The absence of A and B specific molecules in 
a group O individual might be due to enzyme inactivity as a 
result of mutation which renders the glycosyl transferase 
inactive, or due to a complete repression of the enzyme 
synthesis. 
The H gene is responsible for the synthesis of the A 
and B precurser carbohydrate chain. This locus controls the 
enzyme which transfers L-fucose to the terminal galactose of 
the oligosaccharide. Liberation of L-fucose from H reacting 
substances result in a loss of H specificity. Individuals 
of the "Bombay" or Oh phenotype do not have any detectable 
A, B or H activity on the red cellso Homozygosity for an 
inactive allele h, as suggested by Levine (10), could explain 
the complete absence of H activity. This locus is indepen-
dent of the ABO locus. The removal of a galactose residue 
eliminates the "Bombay" type specificity. This galactose is 
linked to an N-acetylglucosamine residue either by a {!;-1, 3 or 
6. 
by a (d-1,4 glycosidic bond. The corresponding type 1 and 
type 2 chains are indicated in Figure 1. The genes control-
ling the biosynthesis of this precurser oligosaccharide 
chain have not yet been identified. 
The 'Lewis' locus also effects the biosynthesis and 
hence the antigenic specificity of the water soluble glyco-
proteins in mucous secretionso Oligosaccharides with Lea 
specificity contain an L-fucosyl residue attached in ol.-1,4 
linkage to the penultimate N-acetylglucosaminyl residue in 
the chain. The carbohydrate chain is the same as that of 
one of the two types of chains which by addition of an L-
fucosyl residue to the terminal galactosyl unit give rise 
to the H specificity. Leb specificity is expressed if two 
L-fucosyl residues are linked to the precurser oligosacchar-
ide; one is attached to the terminal galactose through an 
~-1,2 and ' the other through an o<'-1,4 glycosidic bond in 
the type 1 precurser molecule (7). One important aspect of 
the 'Lewis' locus is the lack of participation in the bio-
synthesis of blood group substances present in the erythro-
cyte membranes. Lewis specificity is acquired by the cells 
from the serum unlike the ABO specificity which is under the 
cell s intrinsic control mechanism. 
Most of these structural works were done on 'water-
soluble' glycoproteins. Structural understanding of mole-
cules carrying blood group specificity in the erythrocyte 
membrane came from the study of an 'alcohol soluble ' 
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glycolipid fraction (11). In the last two decades large 
numbers of glycosphingolipids have been isolated and charac-
terized from erythrocytes. These molecules contain various 
fatty acids, sphingosine, neutral hexose and N-acetylgalactos-
amine in a molar ratio of 1:1:3:1. Yamakawa, who subsequently 
named this fraction "globoside", isolated glycolipids which 
contained neuraminic acid in addition to the usual carbo-
hydrates (12). The currently accepted structure for a 
typical globoside molecule from human erythrocytes, as 
suggested by Yamakawa, Nishimura and Kamimura (13), is 
depicted in Figure 2. Numerous other globosides have now 
been isolated and characterized. They vary in carbohydrate 
content; fucose, glucose, galactose,N-acetylgalactosamine, 
N-acetylglucosamine and sialic acid are present in varying 
molar amounts. These molecules appear to be specific for 
blood groups A and B; similar attempts to isolate H-active 
glycolipids were only recently successful (14). Hakomori 
and Strycharz were able to purify three different fractions 
of glucosphingolipids with A blood group activity; they 
shared a similar basic composition containing glactose, 
glucose, fucose, N-acetylglucosamine and N-acetylgalactos-
amine in ratios of 2-4:1:1:1:1. One of these three A-active 
glycolipids contained a unit or two of sialic acid. Cells 
from a group A individual with A2 subgroup specificity con-
tained only two of these glycolipids. The A2 subgroup is 
known to have less A antigen expressed on the cell surf ace 
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9. 
than on A1 subgroup cells (15). This finding of Hakomori 
suggests that there are qualitative molecular differences 
in addition to quantitative difference between the two sub-
groups, as had been earlier indicated by the common existence 
of Ai-specific antibodies and lectins. 1 mg of glyco-
sphingolipids with A specificity was obtained from five liters 
of blood. Glycolipids with group B activity were also 
obtained from erythrocytes in a yield of 1 mg per 30 liters 
of blood. Only two fractions were found, one of which 
contained sialic acid. Both fractions were missing N-acetyl-
galactosamine. One other glycosphingolipid .was isolated from 
group 0 cells in a yield of 1 mg per 60 liters of blood. This 
fraction contained glucose, galactose, fucose and N-acetyl-
glucosamine but no sialic acid or N-acetylgalactosamine and 
was active in the inhibition of both H and Leb hemagglutina-
tion. 
The question whether glycolipids are the only fractions 
carrying A, B and H blood group activity in human erythrocyte 
membranes has been raised recently. Red blood cell membranes 
contain approximately 8"/o carbohydrate by weight; only a 
fraction of this carbohydrate is present in glycolipids. 35-
40% of the total sialic acid of erythrocytes is present as 
sialoglycopeptides {11). Most of the membrane proteins have 
carbohydrate attached to them. These glycoproteins have 
been studied with respect to blood group activity. Zahler 
(16) demonst~ated complete monomerization of stromal proteins 
10. 
and lipids in 2-chloroethanol. Chromatography of solubilized 
erythrocyte stromata on LH-20 columns in 95% methycellosolve 
resulted in a fraction free of lipid, which contained 85% of 
the membrane protein and most of the stromal sialic acid. 
This glycoprotein fraction displayed (A and B) blood group 
activity. Recombination of the glycolipid and glycoprotein 
fractions resulted in the formation of aggregated which were 
only slightly less active than the original stromata. MN-
active carbohydrate-rich proteins have been also isolated 
by a 'phenol-extraction method' worked out by Westphal (17). 
Springer succeeded in the isolation of a homogeneous, highly 
active MN-fraction (18). Amino acid analyses of these prep-
arations reveal high concentrations of threonine, serine and 
glutamic acid. The molar proportions of sialic acid:hexos-
amine:hexose were approximately 1:1:1. Cook and Eyl.ar, in 
contrast, found a proportion of 1:3:2 in the M-substance and 
a relation of 2:2:1 in the N-substance (19). Results from 
enzymatic studies with different neuraminidases allowed the 
conclusion that sialic acid in a terminal position is largely 
responsible for the specificity of the M- and N-antigenic site. 
Whittemore et al. (20) extracted stromata twice with 
n-butanol, producing over 80% solubilization of the membrane 
proteino The initial extract contained_ 5% of the lipid 
present in intact stromata. The second extract contained no 
lipids or glycolipids detectable by thin layer chromatography 
on silica Gel G using a solvent ·· system of ~hloroform:methanol: 
water 56:65:4. The solubilized glycoprotein possessed A, B 
11. 
and H activity comparable to that of the intact ghosts at 
the same protein concentration. H activity could not be 
demonstrated in preparations from group A1 erythrocytes but 
was present in glycoproteins prepared from group O and 
group A2 erythrocytes; the former exhibited greater activity. 
The number of A-specific molecules per erythrocyte 
surface has been estimated to be 1.2 x 106 A1 sites per cell 
(21) . Assuming a molecular weight of 1800 for the blood 
group active glycosphingolipid isolated by Hakomori and 
Strycharz (14), one would expect to recover 100 or 150 mg 
of glycolipids from 10 liters of blood if all the antigenic 
activity were present in this fraction. The reported low 
yield of 1 mg suggest that other molecules might also be 
involved and the glycoprotein fraction would qualify best 
for this role. 
Exact information is not yet available on the molecular 
structure of other blood group antigens. Glycoprotein pro-
ducts of the histocompatibility (H-2) locus have been solubi-
lized from two murine strains (22). Most of the peptides of 
these glycoproteins from H-2b and H-2d strains were identical; 
however, three peptides of the H-2b and four peptides of the 
H-2d preparation were unique. The results were consistent 
with the hypothesis that protein primary structure determine 
wholly or in part the histocompatibility alloantigenic 
activities. 
We are only at the beginning of membrane protein solu-
bilization and fractionation. The cellular antigen molecules 
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represent an important class of immunological receptors, and 
their molecular structure is a key to the understanding of 
the genetically determined spectrum of individual specifi-
cities. 
The I blood groups in man 
IgM macroglobulins from the sera of patients suffering 
from chronic cold hemagglutinin disease often agglutinate 
human adult red blood cells when tested at lower than body 
temperature. The name "I" was given to the corresponding 
antigen by Wiener et al. (23). This antigen has a character-
istic slow maturation, and an almost universal occurrence. 
It is a frequent target of 'cold agglutinin type' autoimmune 
disorders. 
Wiener et al. (23) tested erythrocytes from 22,000 
random adult individuals with a cold agglutinin serum and 
found five donors whose red cells were not agglutinated. 
These adults apparently had very little or no I antigen and 
their sera contained anti-I isoagglutinins. Erythrocytes 
which failed to react .with anti-I sera were classed as I-
negative or i. There are two general types of non reactors: 
i 1 is usually found among Caucasians while i 2 is usually 
found among Negroes and only occasionally among Caucasians. 
In 1960, Marsh and Jenkins discovered a serum later designat-
ed as anti-i, with antibodies able to agglutinate I-negative 
cells preferentially. This would indicate that the absence 
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of I-specific molecules on the erythrocyte surface is asso-
ciated with the expression of a different molecular entity 
with i-specificity. 
The relationship between I and i antigens has been 
studied by Marsh (24), who demonstrated an apparent recipro-
cal serological relationship on the red cells during the first 
year of a child's life. He found that infants at birth are 
of the phenotype i. Erythrocytes of 62 normal infants with 
ages ranging from two days to four years were tested with 
anti-I and anti-i sera in parallel. The results demonstrated 
that shortly after birth the i-reaction becomes steadily 
weaker, while the I reaction becomes stronger. Normal adult 
I-i status is established at about 18 months of age. The 
I-i relationship was also studied by Bingham (25), who made 
a longitudinal investigation of 127 Negro infants followed 
from birth through the second year of life. In this study, 
no evidence was found to suggest a reciprocal relationship 
between I and i antigens. The gene frequency analysis of the 
infants, mothers and the mother - child combinations of the 
proposed i-phenotypes were in agreement with the hypothesis 
that anti-i identifies an antigen that is inherited as a 
simple Mendelian autosomal dominant trait . Bingham's results 
also suggest that the i-antigen of cord red cells is cross 
reacting but not identical to the i-antigen that appears 
shortly after birth. These observations are in agreement 
with the hypothesis that I and i-specificity represent two 
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blood group systems rather than one, and that the genes 
responsible for the expression of these antigens are not 
allelic. 
A considerable amount of information exists concerning 
certain disease states and the I-i antigens (26). The red 
cells from patients with Thalassemia major react strongly 
with anti-i sera, just as newborn infants' cells do, but the 
reaction with anti-I sera is like that of healthy I-positive 
adults. Similar observations were reported by Giblett and 
Crookston (27) and by Hillman and Giblett (28) who showed 
that erythrocytes from patients with hypoplastic anemia, 
chronic hemolytic anemia and acute leukemia were agglutinated 
strongly by anti-i sera. They have found no corresponding 
decrease in I-activity. Their results are indicative of a 
possible relationship between the intramarrow transition 
time during erythropoiesis and the amount of i-antigen 
expressed on red cell surfaces. McGinness et al. (29) observ-
ed that in leukemia, the amount of I-antigen was depressed~ 
patients were being misclassified as I-negative. They 
reported that I expression increased when the disease was in 
remissfon. One case of leukemia has been described by Jenkins, 
et al. (30), in which the I-antigen was depressed and the i-
antigen's expression was increased. Observations to the 
contrary have been published by Ducos (31), who found no 
apparent difference between normal red cells and those from 
leukemia patients using and auto-anti-I serum from a normal 
15. 
I-positive subject. All of these observations were made on 
the basis of serological techniques, and no molecular 
studies were conducted to measure the number of antigenic 
sites per erythrocyte surfacee Such a biochemical approach 
will be necessary because of the uncertainties due to varia-
tions in agglutinating capacity among the anti-I sera and 
the lack of precisely defined anti-i sera. 
The molecular structure of I-antigen is not known. Two 
indirect studies suggest that the specificity is determined 
by carbohydrates. First, Marcus, et al. reported the action 
of enzymes from Clostridium terium on the I-antigenic deter-
minant of human erythrocytes (32). Partially purified beta-
galactosidase and beta-glucosaminidase were used to modify the 
stromal surface. This treatment resulted in a decrease in 
ability to absorb anti-I agglutinins and in the release of 
galactose and N-acetylglucosamine as monosaccharides. 
Stromata from erythrocytes of blood group A1 were altered more 
rapidly and extensively than preparations from group O cells. 
Yakulis et al. (33) found that the I-antigen of rabbits and 
human A1I erythrocytes was inactivated by ~-galactosidase. 
They tested several galactosides for the inhibition of two 
different human cold agglutinins with anti-I specificity 
with no success. These same o<'-galactosides inhibited 
experimentally produced rabbit anti-I cold agglutinins. It 
is difficult to interpret these experiments in terms of the 
I-antigen's molecular structure: one may only conclude that 
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the integrity of oligosaccharide chains on erythrocyte 
surface is necessary for I-specificity. 
Numerous serological observations indicate a relation-
ship between the ABO and the I system (5). The first clear 
example was the finding of an anti-I serum which reacted 
stronger with Al than with A2 or 0 cells (34). Since then, 
numerous examples of sera that react stronger with OI than 
A1I cells, or with A1I than with OI, and sera that react 
preferentially with BI cells have been reported. The increas-
ing number of reports on the possible ABO and I relationship 
remained a puzzle, because no secreted I-activity has been 
reported on water soluble glycoproteins with blood group 
activity. Recently, Marsh et al. (35) reported the inhibi-
tion of anti-I sera by human saliva and by hydatid cyst fluid. 
The concentration of I-inhibitory substance found in the 
saliva of newborn infants and i adults was comparable to that 
found in normal I-positive adults. This indicates that the 
presence of I-substance in the saliva does not reflect the 
I status of the red cells. A possible relationship between 
the P and the I blood group systems has been reported by 
Jenkins et al. (36) and Issitt et al. (40). 
The almost universal occurrence of I-antigen on red cell 
surfaces indicates a possible structural role in the membrane. 
In this case topographic vicinity could explain some of the 
interrelations between I and other blood groups. The very 
frequent 'public antigens' such as I could have their speci-
ficities0 expressed on molecules which are structural 
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entities of the red cell membrane, and therefore their 
biochemical investigation could reveal important information 
on the molecular assembly of membranes. 
At present there is a difference of opinion with regard 
to the number of I antigenic receptor sites present on red 
cells. The number of cold agglutinin receptor sites was 
estimated to be 32,000 by Olesen (37), using formalin treated 
I-positive cells. Evans et al. (38) estimated the number of 
I-receptor sites on human erythrocytes as 500,000,using high 
titered cold auto-anti-I antibodies labeled with radioactive 
iodine. Rosse et al. (39) determined the maximum number of 
anti-I antibody molecules which can attach to human red cell. 
The values represent the minimum number of antigen sites, 
because the 19S IgM molecules have five or more available 
binding sites. As many as 500,000 to 700,000 antibody mole-
cules were observed per normal cell. The surface area of 
2 
red blood cells was measured and found to be 120 µ • Assum-
ing an average number of 3 antigen sites combined with each 
IgM molecule , and a uniform distribution of antigens on the 
cell surface, one can estimate that the average distance 
between I-specific molecules may be 100 A0 • It is fair to 
conclude that molecules with such a surface density have a 
role in the molecular structure of the membrane. 
Agglutinins associated with the I blood group system 
Two major types of anti-I agglutinins have been 
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characterized. One occurs in normal individuals who lack an 
adequate amount of I-antigen and are i-phenotypes; these 
have been referred to as 'natural' or isoagglutinins. The 
other type occurs in I-positive individuals usually follow-
ing certain infections, and has been called auto-agg1utinins(S). 
Natural anti-I agglutinins have been found regularly in 
the serum of I-negative individuals of i1 and i 2 phenotype. 
Some variations have been found according to the source of 
the serum. Anti-I antibody molecules from i 2 donors fail to 
react with i 1 or i 2 cells. Anti-I agglutinins from i 1 pheno-
type donors do react weakly with i 2 cells. These observations 
are analogous to the agglutinins of the ABO subtypes, where 
antibody moiecules directed against the A antigen from some 
A2 individual are able to agglutinate A1 cells.These agglutin-
ins are 19S IgM molecules, which are particularly sensitive 
to the antigen density on the cell surface. Anti-I cold 
agglutinins have been reported by Adinolfi (41) in a high 
percent of umbilical cord sera. It is not clear whether 
these agglutinins are produced in response to maternal I 
antigen in utero. They behave as 'naturally-occurring' IgM 
molecules and are of fetal origin. 19S anti-I agglutinins 
do not cross the placenta; none could be detected in the 
sera or on the cells of the normal babies of an i 1 or of 
and i 2 mother (5). 
Auto-anti-I agglutinins have been found in the sera of 
patients suffering from acquired hemolytic anemia of the 
cold antibody type (26). Cold agglutinins are antibody mole-
cules which agglutinate erythrocytes at lower than body 
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temperature. These immunoglobulins are synthesized in 
response to infections by any of a large number of microbial 
agents. Specific cold agglutinins have been found in connec-
tion with Lewis and the P systeme Sera which were earlier 
identified as "nonspecific chronic cold auto-agglutinating" 
contained anti-I IgM molecules: Jenkins et al. {36) found 
that all of 50 patients with cold agglutinins had anti-I 
antibody. 
Cold agglutinins with I-specificity are present in the 
sera of some patients with "primary atypical pneumonia", an 
upper respiratory tract infection associated with a group of 
Pleuro-Pneumonia-Like-Organisms (PPLO). The question arises 
whether these antibodies are produced as a result of biochem-
ical alterations on the host's red cell surface or are 
directed against an antigen similar to the I-antigen present 
on the surface of PPLO or viral agents. Schmidt et al. (42) 
reported that 18 of 25 Mycoplasma {PPLO) strains destroyed 
the I-receptors of normal red cells after in vitro incubation. 
This observation could not be reproduced by Altucci et al. 
(43) who concluded that the interaction of Mycoplasmas and 
erythrocytes has no effect on the expression of I-antigenicity. 
Feizi, et al. {44) found no evidence that the cold 
agglutinins have antibody activity against Mycoplasma pneu-
moniae, indicating a lack of I-antigen on the surf ace as 
detected by serological techniques. It is possible that the 
antigen is present on or in the organism in amounts too small 
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to be detected, but still responsible for the anti-I agglu-
tinin response. The organisms were grown in vitro for these 
experiments and it is also possible that the I-antigen was 
lost as a result of culture techniques. Such changes in 
surface antigens have been reported on chick embryo cells 
grown in culture. An alternative explanation would be that 
Mo pneumoniae during in vivo infections alters the I-antigen 
and renders it "autoantigenic". This could be brought about 
by enzymatic alteration or by hemolytic activity. Evidence 
in favor of such a mechanism has been reported by Feizi et 
al. (45), who claim that the reaction product of I-antigen 
with M. pneumoniae, rather than the microbial organism alone, 
may be responsible for the production of cold agglutinins in 
man.; 
Experimental production of cold agglutinins in rabbits 
has been reported by Costea, Yakulis and Heller (46). Rabbits 
with I-positive erythrocytes have been injected with heat-
killed Listeria moncytogenes (HKLM), a PPLO-like organism, 
isolated from a patient with Listeria monocytogenes septi-
cemia and cold agglutinin hemolytic anemia. The cold agglu-
tinins produced by the rabbit were I-specific, with high 
agglutination titers for autologous and allogeneic rabbit 
erythrocytes and human adult cells. Newborn rabbits' erythro-
cytes and human cord cells were only weakly agglutinated by 
the rabbit cold agglutinins. The authors found that absorp-
tion of the immune serum with HKLM at 37°c removed all the 
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I-specific agglutinating activity - an important finding 
which suggests that the erythrocytes and the microbial agents 
share cross-reacting antigens. The antigens from HKLM bind 
antibody at body temperature while the erythrocyte-associated 
antigens react only at lower than body temperatures. The 
same investigators recently reported the results of experi-
ments in which live and formalin or phenol treated suspensions 
of M. pneumoniae were injected into I-positive rabbits and 
I-negative CF1 mice. They observed high titers of I-specific 
cold agglutinins in both species within one week after immu-
ization. Although these cold agglutinins from humans, rab-
bits and mice have anti-I specificity, their affinity for 
oligosaccharide ligands differ as determined by inhibition 
studies with various model galactosides. The results of 
these experiments indicate that I-specific cold agglutinins 
are produced in rabbits and mice in response to M.pneumoniae 
or Listeria monocytogenes which cross-react with the I-
erythrocyte antigen system, and their production does not 
require steric or structural modifications of the I-antigen 
of the red cells (47). 
Recently, Costea et al. (48) reported the occurrence of 
cold reacting antibody in NZB/B1 mice. This inbred strain of 
mice develops hemolytic anemia of varying severity. Anemia 
appears at an age of six to nine months among the males and 
around twelfth month in the females. Affected mice show 
reticulocytosis, splenomegaly, jaundice, anemia and elevated 
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antibody titer. This autoimmune condition is inherited but 
its pattern of inheritance is not simple. The main manifes-
tation of the disease is Coomb's-positive hemolytic anemia 
with significant similarities to human autoimmune conditions. 
NZE/B1 mice throughout life produce cold reacting antibodies 
with specificity relating to the I-erythrocyte antigen in 
men. Mouse erythrocytes do not carry the I-antigen, but it 
is widely distributed in several tissues. Newborn mice from 
certain strains, such as cF1 , produce cold reacting anti-
bodies when injected with cell-free filtrates from NZB/B1 
mouse spleen. The untreated offsprings of these injected 
animals also synthesize this type of antibody, suggesting 
that the immune response is induced by an infectious agent. 
High incidence of cold autoagglutinins with anti-I 
specificity has been reported by Layrisse (49) among the 
Yanomamaindians of Venezuela. These cold agglutinins react 
with cells having intermediate I-antigen density. 84% of 
Yanomama Indians had these autoagglutinins, in contrast with 
the Warao Indians who had none. These two tribes inhabit 
similar tropical areas in the Orinoco Delta of Venezuela, 
where protozoon, bacterial and viral agents have about equal 
chance to disseminate among the people. These tribes come 
from one ethnic group, which split up about 4,000 years ago 
as indicated by blood group frequencies and each represent 
an inbred population. Genetic implications of the distri-
bution of cold agglutinins have been discussed by Layrisse. 
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Recently Bloom et al. (50) reported a high frequency of 
complex inter- and intrachromosomal aberrations in the 
leukocyte of Yanomarna Indians. It is not clear that these 
observations reflect a natural condition, rather than a tech-
nical artifact: there is reason to believe that the chromo-
some breakage occurred in cell culture, and may reflect an 
infection. High incidence of cold agglutinins directed 
against the I-blood group system has been reported in a 
Melanesian population living in a climate similar to that 
of the Orinoco Delta in Venezuela (51). Serologically, the 
I-positive erythrocytes from Melanesians and Caucasians are 
identical with respect to their I reactions. Neither the 
Chinese or the Caucasians who live in the same tropical 
environment have a high frequency of these cold agglutinins. 
This observation again implies a possible genetic basis for 
the disorder. 
The molecular structure of cold agglutinins with anti-I 
specificity has been studied extensively. These autoagglu-
tinins belong to the 19S IgM macroglobulin class. The mole-
cules consist of five identical subunits held together by 
disulfide bonds. Each subunit has two light and twoµ type 
heavy chains (52). The transient cold agglutinins, defined 
as antibodies produced as a result of microbial infection, 
are heterogeneous molecules containing both K and L types of 
light chains (53). Their binding specificity varies, and only 
a fraction of the antibody population has anti-I specificity. 
24. 
These cold agglutinins resemble other anti-blood group anti-
gen antibodies. However, cold agglutinins isolated from the 
sera of patients with chronic cold agglutinin hemolytic anemia 
contain only type K light chains (53,54). Harboe et al . 
studied 37 cold agglutinins and found exclusive occurrence 
of K type light chains. Feizi reported three IgM prepara-
tions from patients with chronic hemolytic anemia, which 
contained light chains of the L type. Only one of these 
preparations had anti-I activity (55). On the basis of 
restricted electrophoretic heterogeneity of light chains, 
and single amino acids observed at the amino-terminus, 
Cohen and Cooper (56) suggested that the proteins are of 
monoclonal origin. This would imply that the antibodies are 
homogeneous, like the myeloma type proteins. However, such 
conclusions need more careful consideration. Chemical dif-
ferences among cold agglutinins from individual humans were 
also reported by Cohen and Cooper. Both heavy and light 
chains varied as much in amino acid composition as do 
myeloma proteins of a given type, chosen at random. The 
light chains had Asp or Glu as N-terminal amino acids. The 
chemical individuality of cold agglutinin µ-chains was also 
shown by dif fernces in hexose, fucose and glucosamine con-
tent. 
The described restricted heterogeneity of cold aggluti-
nins is similar to the antibodies from antipneumococcal sera 
as reported by Jaton et al. (100). Antibodies of sufficient 
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homogeneity for sequence studies were isolated in high con-
centrations from rabbits immunized with pneumococcal vaccines. 
A unique sequence for the N-terminal 11 amino acid residues 
of the light chains indicate a great restriction of hetero-
geneity. Unequivocal indication of homogeneity, however, 
will only be obtained through complete amino acid sequence 
determinations. 
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Changes of the erythrocyte surface during development. 
One of the important aspects of the I blood group 
system is the slow appearance of the I-antigenic specificity. 
Fetal erythrocytes have i-phenotype, which gradually changes 
into an I-positive phenotype during the period of one to 
two years after birth. The erythrocyte surface without the 
I-antigen therefore appears as "embryonic-like", and the 
molecules exposed on this surf ace could be ref erred to as 
"embryonic"-antigens. The antigen molecules do not have to 
be structurally different; the change in specificity could 
be a function of a changed topographic arrangement. 
The development of the ABH antigens of the red cells 
has been studied by numerous investigators (5). The A and 
B antigens are detectable long before birth. The A antigen 
was found in a 37 day old fetus. A difference in the number 
of antigenic sites in the adult and cord cell surface, has 
been reported by Economidou et al. (21). The number of 
A-antigen sites was estimated as between 2.5 and 3.7 x 105 
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on A1 cord red cells, and between 8.1 and 11.7 x 10 on 
adult red cells. Only a twofold difference was found between 
A2 adult and cord cells. A similar increase in the number 
of B-antigenic sites has been reported (2.1) . A difficulty in 
typing cells from the umbilical cord is in the determination 
of subgroup types, because A1 cord cells frequently type as 
A2-like cells. This observation further substantiates 
the suggestion, discussed earlier in this thesis, that the 
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difference between the two subtypes may in part by the 
number of A-specific molecules on the cell surface. Type-A 
cord cells also have detectable H-antigen on their surfaces, 
which fits with the suggestion that incomplete oligosacchar-
ide chains are responsible for the lower number of A-anti-
genic sites. It is not known whether these oligosaccharides 
are incomplete because of the shortage of enzymes responsible 
for their bioeynthesis or because of a shortened marrow trans-
ition time. 
Antigens of other blood group systems are well expressed 
at birth. Very interesting exceptions have been reported by 
Reed and Milkovich. (57), who have tested the accuracy of 
blood grouping of cord blood specimens with special reference 
to the ABO, Rh, MNSs, Kell, Duffy, Lutheran and P system. 
After testing 9,293 individuals at birth and after an age of 
five years they found in both Negroes and Caucasians a very 
high frequency of false negatives in the cord blood grouping 
in the P system and a very significant occurrence of false 
negatives in Lua grouping. These findings indicate that the 
molecules responsible for these antigenic specificities are 
not fully expressed on cord erythrocytes . It is interesting 
to note that these same antigens, together with the I antigen, 
are almost the exclusive targets of cold autoagglutinins (26). 
The development of these antigens, or the establishment of 
the surf ace molecular distribution characteristic of a 
mature adult cell, may take place at the time when self-
tolerance is established. It is possible that the high 
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incidence of autoimmune disorders directed against these 
antigens is related to their immature development or expres-
s ion at an early age. 
Antigenic differences between fetal and adult erythro-
cytes have been reported in other species as well. For 
example, in cattle Stormont et al. (58} reported that the 
J-antigen was missing on the erythrocytes of embryos from 
J-positive dams. This antigenic specificity is acquired 
later by absorption of a water soluble substance from the 
blood plasma. 
An antigen on the red cells of young chickens that is 
not detectable on the red cells of adults was found by 
Owen and Mallek (59}, using a hemolytic test system. Sanders 
(60}, who further investigated this observation, reported 
that the antigen is present on all red blood cells at hatch-
ing. Their disappearence starts about 50 days after hatch-
ing and the antigen is undetectable by 120 days of age. 
Studies aimed at elucidating the mechanism of the developmen-
tal antigenic change suggested that the antigen was lost 
during development rather than coated by a serum component, 
a phenomenon noted earlier by Sanders with respect to a 
developmentally changing antigen on the red cells of brown 
trout (97). 
The development of antigens controlled by a histocompa-
tibili ty locus has been studied by several workers, includ-
ing Klein (61) and Gold and Freedman (62). The H-2 antigens 
in mice were detectable only immediately before birth. The 
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amount of antigens increased rapidly after birth and reached 
adult strength in a few days. The answer to the question of 
the presence or absence of H- 2 antigens in early embryonic 
tissues depended on the method used for their detection. 
The method of hemaglutinin absorption gave a negative answer 
while indirect techniques provided evidence for the presence 
of residual amounts of antigens. The antigen density on cell 
surf ace increased slowly during early embryonic stages but 
a very rapid increase was observed immediately before and 
after delivery. Embryonic cells, cultured in diffusion 
chambers in an isologous adult host, exhibited a striking 
increase in the antigen expression which coincided with the 
period of a hypothetical delivery of the fetus. The results 
suggest that the embryonic cells retained their own "calen-
dar" of antigenic maturation. 
Additional developmental aspects of normal and abnormal 
cell surf ace genetics have been recently reviewed by Boyse 
and Old (63). The particularly interesting TL antigens in 
mice are controlled by the Tla locus. All mice, except 
those of thymocyte phenotype Tl.1,2,3 carry repressed Tla 
structural genes which are derepressed in the event of 
leukemia. These antigens, detectable on embryonic tissues, 
are expressed only on normal thymocytes in the adults. 
Three things are necessary for the expression of TL.l anti-
gen in normal thymocytes: a structural gene which all mice 
possess, the allele for the expression of TL.l and an indu-
cer of TL synthesis. This inducer is presumably present in 
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the thymus. Only in the event of thymic leukemia are there 
cells outside of the thymus with TL+ antigens. For example, 
thymocytes of C57BL/6 strain of mice are then atypically 
TL-. In the leukemic cell due to a genetic derepression the 
phenotYJ:Ebecomes identical with the genotype and the cells 
become TL 1,2,-,.4. Repression is re-established in the pre-
sence of anti-TL antibody, and the cellular phenotypes can 
therefore be "modulated" by the experimenter. The molecular 
mechanism responsible for this antigenic modulation is not 
yet understood. 
The appearance of embryo-specific molecules in patients 
with primary cancer of the liver has been reported by 
Tatarinov et al. (64). This phenomenon was first observed in 
mice and rats with transplantable hepatoma. Animals with the 
tumor produced an embryonic alpha-globulin, a specific 
antigenic constituent of fetal serum. Adenocarcinomas have 
also been reported to produce "carcinoembryonic" antigens, 
found in the serum of patients with cancer of the colon and 
rectum (65). Similar constituents were found in normal 
embryonic and fetal gut, pancreas and liver during the first 
two trimesters of gestation. It is interesting to note that 
most of these patients have autoagglutinins with anti-i 
specificity. The I-negative or i-specificity can be consider-
ed as "embryonic specificity"; it would therefore be inter-
esting to find out if the carcinoembryonic antigens in the 
serum are glycoproteins with I blood group system activity. 
31. 
The change from I-negative to I-positive red cell speci-
ficity takes place about the same time as does the change from 
fetal to adult hemoglobin inside the cells. A schematic rep-
resentation of the erythropoietic system's development is 
illustrated in Figure 3. This simplified diagram is based 
on the currently accepted understanding of the major events 
in the differentiation of hematopoietic stem cells, as summar-
ized at the XII Congress of the International Society of 
Hematology (66). 
Five major classes of polypeptide chains make up the 
hemoglobins of a human individual at various stages of his 
development. The chains, designated as o{ , {J , o, d', and f, 
account for the different species of hemoglobin. Dimers of 
the € chain in equilibrium with the tetramer form are refer-
red to as Hb Gower1 • This is the first hemoglobin to appear, 
it is synthesized by nucleated cells differentiated from the 
yolk sacw . During the first month of gestation the cells 
begin to synthesize~ chains. Hb Gower 2 consists of two E 
and two o< chains. Betke ( 67) claims that cells of the same 
organ, in a later stage of development, begin to synthesize 
fetal hemoglobin, which consists of two 0 and two cX. chains. 
Migrating stem cells appear in the liver and the spleen 
around the third month of gestation. Fetal hemoglobin is 
the predominant product in the erythrocytes derived from 
erythropoietic differentiation in liver and spleen. Around 
the fifth month of embryonic development, the site of 
Time of 32. 
Sites of cry1hropoicsis: 
! 
Bone Morrow 
Lymphopoieses 
3 
4 
5 
6 
7 
8 
9 
tsirt h 
® =cell nuclei 
~ = messenger RNA 
f:.::~::.J Hb Gower 1 =. E 2 ~ E4 
mzi Hb Gower2 = a2 E2 
. .. CJ HbF ;:. a2 Y2 
~ HbA = a2f32 
-----o- =migrating stem cells 
@ = erythropoietin sensitive eel ls 
Figure 3. The development of the erythropoietic syst~~. 
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erythropoiesis changes gradually to the bone marrow. Pre-
sumably stem cells of the same organ populate the bone 
marrow, and by the seventh and eight months of gestation 
the marrow becomes the major site of erythropoietic activity. 
About this time the biosynthe sis of adult hemoglobin s tar t s, 
but active synthesis of fetal hemoglobin has been reported 
in the bone marrow. These results indicate that there is 
no limitation of the synthesis of a certain type of hemo-
globin to a certain hematopoietic site. It is believed that 
common stem cells give rise to the lymphopoietic prolifera-
tion. Figure 3 also indicates the presence of a so-called 
"early differentiated 11 cell population in the bone marrow, 
which is sensitive to specific controllers such as erythro-
.poietin. 
In normal adults, the bone marrow is the only site of 
erythropoiesis. Under pathological conditions in which 
there is a failure in hematopoiesis in the bone marrow , 
such as hemolytic anemias, the spleen and liver may again 
become centers of erythroid cell development during adult 
life (68). 
Erythroid differentiation in fetal mice follows a simi-
lar pattern, with the exception of adult hemoglobin synthesis. 
Nucleated erythrocytes originating in the blood islands of 
the yolk sac appear during days 8-12 of gestation and synthe-
size embryonic hemoglobin predominantly (69) . A second popu-
lation of non-nucleated erythrocytes originating in the liver 
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is present from 12-18 days of gestation and synthesizes 
predominantly adult hemoglobin. 
The sequential derepression and repression of the non-
allelic genes responsible for these hemoglobin chains repre-
sent an attractive system to study the regulation of protein 
synthesis during embryological development and tissue differ-
entiation. Several inherited defects have been studied as 
they effect the biosynthesis of the polypeptide chains of 
hemoglobin. Among the most extensively studied defects are 
those collectively known as the thalassemias. They appear 
to be determined by a series of distinct abnormal genes, in 
different heterozygous and homozygous combinations. Thalas-
semias have been classified according to the polypeptide 
chain primarily concerned in causing hemoglobin deficit. 
Thus in the so-called beta-thalassemias, the main defect 
appears to involve beta chain synthesis, whereas in alpha-
thalassemias alpha-chain synthesis is primarily affected. 
It is probable that a number of different mutant genes can 
cause this type of abnormality and although they each result 
in the repression of one of the polypeptide-chain syntheses, 
the degree to which this occurs appears to vary considerably 
from one gene to another (70). It is interesting to note 
that in both beta and beta-delta- thalassemia, fetal hemo-
globin synthesis increases and is unevenly distributed in 
the erythrocytes. This observation is in contrast with the 
observation of even distribution of fetal hemoglobin in 
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individuals with hereditary persistent fetal hemoglobin 
disorder. These observations indicate that different non-
structural genetic loci are involved with the regulation of 
hemoglobin subunit biosynthesis. Although the exact molecu-
lar mechanisms of these regulatory events are not yet under-
stood, the system provides an excellent approach for the 
study of regulation of protein synthesis during development. 
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OUTLINE OF THE RESEARCH PROBLEMS INVESTIGATED 
The development of I-antigen and postnatal changes in 
hemoglobin were examined in human infants, to see whether the 
developmental changes in these two attributes are correlated 
in individual cells in such a way as to suggest that they 
have common biochemical control mechanisms. Similarly, the 
rates of A-antigen and I antigen site development were com-
pared, to test for possible common control or close asso-
ciation. 
Experiments were performed to modify the surf aces of 
erythrocyte stromata with enzymes and chemical reagents in 
order to obtain information on the possible molecular 
basis of I antigenic spe~ificity. 
Stromata from human adult I-positive erythrocytes were 
fractionated in order to isolate molecular fractions with 
ABO and I specificity and to deal quantitatively with the 
molecular species responsible for blood group activity. 
Molecular fractions from the erythrocytes of postnatal 
infants were also compared for ABO and I specificity. 
One advantage in studying the I-antigen system in man 
is the availability of well defined, easily purif iable cold 
agglutinin molecules with anti-I specificity. These IgM 
molecules have restricted heterogeneity and their molecular 
structure can be studied by standard methods of protein 
chemistry. Sera with anti-I agglutinins were studied from 
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various patients with chronic cold agglutinin disease, 
postpneumonia cold agglutinin disease and post viral inf lu-
enza cold agglutinin disease. IgM cold agglutins were iso-
lated from several of these sera and their restricted hetero-
geneity established. 
These well characterized protein molecules were used 
in experiments to study the I antigen's development in 
postnatal infants. 
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MATERIALS AND METHODS 
Characterization of anti-I agglutinins 
Anti-I sera were collected for several years from 
numerous sources and screened routinely for cold agglutinins 
and specificity. Standard methods of immunohematology were 
performed as described in the Reference Manual prepared by 
Hyland Laboratories (71), and as outlined by Campbell et al. 
(72). All reagent red blood cells and standard anti-blood 
group sera were. obtained from Hyland Laboratories, Los 
Angeles. Serum concentrations of immunoglobulins were deter-
mined using the Immunodiffusion Plates of Hyland Laboratories. 
Agglutination was performed with the Microtiter System 
developed by Cooke Engineering Company, Alexandria, Virginia. 
Stainless steel loops were used for serial dilution, except 
in inhibition studies where the surf ace tension of the solu-
tions tested for inhibition varied considerably. Glass micro-
pipets were used for dilution of stromata suspensions, and 
the agglutination was carried out in glass test tubes. Each 
test was carried out in triplicate; in case of marginal 
agglutination strength 'blind-reading' by an additional 
individual was obtained. 
Cold agglutinins were incubated at 4°c, unless other-
wise specified, and the agglutination strength was deter-
mined three times, after one, four and twelve hours of 
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incubation. The strength of agglutination was scored as 
follows: 
Assigned agglutination 
stength: 
4+ 
3+ 
2+ 
+ 
Description: 
Agglutinated clumps of cells that 
do not disaggregate by shaking 
the sample. 
Large clumps of cells with a ten-
dency to dissociate. 
Large clumps with loose attach-
ment to each other. 
All cells are present in clumps 
which are small but visible. The 
agglutinated cells sediment 
rapidly under gravitation. 
Weak positive reaction, still 
visible without the use of a 
microscope. 
Negative reaction with easily 
dissociable single cells. 
In all the experiments, only the macroscopically visi-
ble agglutination was scored as positive . Agglutinated 
small cell clumps as observed under the microscope were 
scored as negative in order to avoid unnecessary questionable 
interpretations. Evaluation of agglutination strength is 
not precise 6 but the use of control cells and serial dilu-
tions of antisera make it applicable for scientific investi-
gation. 
Serum from a patient (COH) with postpneumonia cold 
agglutinin disease was a gift from Dr. J.L. Fahey of the 
City of Hope. This patient was an 80-year-old Caucasian 
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woman with a long history of pneumonia; her white cell 
count was normal but a bone marrow examination was consis-
tent with a diagnosis of hemolytic anemia. 
Two sera from patients MAT and HOV, with chronic cold 
agglutinin disease, became available through the courtsey of 
Dr. R. Evans of University of Washington, Seattle, and of 
Dr. E. Shanbrom of Los Angeles. Serum from an I-negative 
Caucasian boy with thalassemia minor with the gift of Dr. B. 
Myrie from the Blood Bank of the Los Angeles Red Cross. 
This patient had numerous operations for congenital glaucoma. 
His sister's erythrocytes were also I-negative in phenotype. 
Serum from patient AB3 was also a gift from the Blood Bank 
of the Los Angeles Red Cross. This patient developed a 
high titer of cold agglutinin with I-specificity following 
a viral influenza. 
Microdroplet cytotoxicity tests were used to detect 
antibodies directed against antigens present on lymphocytes 
(73). Lymphocyte suspensions were incubated with the cold 
agglutinin sera for one hour at 4°c. Complement was added 
and the samples were further incubated for an hour at 4°C 
followed by incubation at 17°c for an additional 30 minutes. 
Lymphocytes were stained with eosin and the numbers of living 
and dead lymphocytes were scored under a phase contrast 
microscopeo 
Isolation of IgM cold agglutinins was carried out accord-
ing to the methods described by Miller et al (52), Lamm et 
alo (74) and Chaplin et al. (75). Combinations of different 
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purification steps were used in order to obtain the highest 
yield and the least amount of contamination by other serum 
proteins. These steps included gel-filtration, ion exchange 
chromatography, sucrose density gradient centrifugation and 
starch gel electrophoresis as described by Kunkel (76) . 
Additional purification and protein concentration were 
achieved by using ultrafiltration on Diaflow membranes 
(Amicon Corp.). Lyophilization was avoided whenever possible 
because the macroglobulin preparations were often difficult 
to redisolve after freeze-drying. The extent of purification 
was examined in successive steps by means of immunoelectro-
phoresis and acrylamide gel electrophoresis in SM urea at 
pH 2.7. The 19S IgM macroglobulin preparation was reduced 
and alkylated in SM Guanidine hydrochloride,using dithio-
threitol for reduction and ethylanimine for aminoethylation. 
The heavy and light chains of the cold agglutinin mole-
cules were separated on Sephadex G-200 columns in SM guani-
dine hydrochloride. The amino terminal sequences of the 
light chains were determined according to Edman (77) using 
an automatic Protein Sequenator. 
The development of the I antigen 
I 
Cord blood samples were obtained through the courtesy 
of Mrs. E. Prestegard of the Pasadena Clinical Laboratory . 
Erythrocytes were washed from the clot with buffered saline . 
The washing procedure was repeated three times at 37°c in 
order to remove any possible fetal cold agglutinins absorbed 
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to the cell surfaces. All samples were studied within 24 
hours after birth. 
Blood samples from postnatal inf ants were obtaine d 
through the courtesy of Dr. J. Wilkins of the u.s.c. Medical 
Center in Los Angeles. Blood was allowed to clot for four 
hours. Cells were washed out of the clot at 37°c and the 
samples were studied within 24 hours of their drawing. 
Erythrocytes were fractionated with respect to their 
I-agglutinability. Cell suspensions (2%) were mixed with 
equal volumes of different dilutions of previously-character-
ized anti-I cold agglutinin sera. The samples were incubated 
at 4°c for two hours and the agglutinated cells were subject-
ed to repeated sedimentation in a clinical centrifuge. Centri-
fugation for 30 seconds at 1,000 rpm sedimented all the 
agglutinated cell clumps. The suspended single cells were 
removed and the agglutinated cells were washedarrl resediment-
ed several times in cold buffered saline. The degree of 
fractionation was followed by microscopic observation. 
Unagglutinated cells were counted in a hemocytometer. The 
agglutinated cells were designated as "I-positive" in 
contrast with the sing1e cells , which were called "I-negative". 
It must be kept in mind that this nomenclature is only for 
convenience, to describe cells which agglutinate or fail to 
do so under the conditions applied; the terminology is not 
intended to imply the absence or the presence of the I 
antigen on two mutually exclusive categories of cells. 
43. 
The amount of fetal hemoglobin was determined by the 
method of Singer et al. (78), using alkali denaturation, 
and by ion exchange chromatography as developed by Jones and 
Schroeder (79) . The hemoglobin content of single erythro-
cytes was studied by the microspectroscopic technique of 
Matioli et al. (80). A Zeiss microscope furnished wi th an 
apochromatic condenser, an apochromatic objective (60X N. A. 
0.85) and a compensatory ocular (8X) lens was made available 
by Dr . G. Matioli of u.s.c . Medical School. Fresh blood 
samples were smeared on a quartz slide (Leitz) and air dried. 
The samples were fixed first in methanol and later in 80% 
ethanol. The optical absorption of 100 randomly chosen 
single cellswas determined for every sample. Adult hemo-
globin was extracted from the fixed erythrocytes by immers-
ing the slide in a buffer of 0.2 M Na2HP04 + 0.1 M citric 
acid, pH 3.30, for 20 seconds. The extracted samples were 
washed with deionized water and air dried. The unextracted 
hemoglobin was quantitated microspectrophotometrically. 
The hemoglobin content of "I-negative" cells was deter-
mined in a similar way. An "I-negative" cell population was 
obtained by mixing on a quartz slide red blood cells with 
10 microliters of undiluted anti-I cold agglutinin serum, 
and agglutinating the samples on the slide at 4°c for 15 
minutes in a small container saturated with water vapor . 
After incubation the smear was examined as described . The 
unagglutinated cells on the slides are referred to as " I 
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negative". In order to find out if fractionation was 
achieved, an equal mixture of adult type A1 1 I and cold type 
A1 ,I cord blood sample was treated in a similar way. The 
unagglutinated cells were predominantly of cord type with 
respect to their hemoglobin content, indicating that fraction-
ation of this mixture was achieved. 
The number of A-antigenic sites per erythrocyte was 
determined by the method of Economidou et al. (21). An IgG 
fraction of a high-titer anti-A human serum from Hyland 
Laboratories was prepared by ion exchange chromatography. 
Fifty milligrams of anti-A containing gamma globulin prepara-
. d . h 10 f . f 125 . tion were reacte wit me o carrier- ree NaI according 
to the method of Greenwood et al.(81). The labeled globulin 
was adsorbed onto 5 million type A1 cells suspended in 2% 
bovine serum albumin. In some experiments the adsorbed 
globulin was eluted at 56°c for 20 minutes and the amount 
of radioactivity in the globulin fraction was determined 
using a Beckman LS-200B Liquid Scintillation System. In 
some other experiments the cells with the adsorbed labeled 
globulin were dissolved in NCS solubilizer (Amersham/Searle) 
and the radioactivity determined. Group O erythrocytes were 
used as controls for nonspecific adsorption in every experi-
menta 
The Chemical and Enzymatic Modification of Human Erythrocyte 
Stromata 
Stromata were prepared from fresh blood by washing the 
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red blood cells three times in 0.15 M NaCl solution followed 
by a wash in 310 milliosmolar phosphate buffer, pH 7.4. The 
packed cells were lysed in 15 volumes of 20 milliosmolar 
phosphate buffer, pH 7.4 for 30 minutes with constant stir-
ring . Stromata were collected by centrifugation in a 
Servall centrifuge using the GSA rotor head at 18,000 g for 
40 minutes. After repeated washings in the low ionic strength 
phosphate buffer, the intact white stromata were resuspended 
to an equivalent of 5% cell suspension with an equal mixture 
of 0.15 M NaCl and 310 milliosmolar phosphate buffer, pH 7.4. 
Anti-A and anti-B serum specifically agglutinated the stromata 
prepared from type A or B cells. Anti-I sera of HOV and MAT 
similarly agglutinated the stromata at 4°c, while normal serum 
gave no agglutination. This indicated that A, B and I 
antigens remain unaltered on the membrane surface after the 
preparation. 
Successful agglutination of stromata was achieved with 
purified macroglobulin molecules from HOV, indicating that 
the clumping was due to the binding of 195 antibody molecules 
with the I antigen. The agglutination showed the same 
temperature response as the intact cells and was completely 
reversible when the temperature was raised to 37°c . I-
activity was retained for several days when kept at 4°c , and 
for several months if the sample was frozen in 30% glycerin 
and kept in liquid nitrogen . Stromata were lyophilized and 
later used in some experiments. The resuspended lybphilized 
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stromata retained over 50% of their capacity to bind anti-A 
or anti-I antibody molecules. Fetal stromata were similarly 
prepared from cord red blood cells. Such preparations fail-
ed to agglutinate with anti-I serum. 
These experiments proved that the stromata were feasible 
material for chemical and enzymatic modifications, and could 
be used to obtain information about the molecular nature of 
the I antigen. 
The specific absorption of antibody molecules by the 
stromata was measured in a Microtiter System. Anti-I serum 
was serially diluted into a suspension of stromata or into 
a solution tested for the presence of I antigen. The dilu-
tions were incubated at 4°C for two to four hours and fresh 
adult cells were used to detect the remaining uninhibited 
anti-I cold agglutinins. All tests were carried out in 
phosphate buffered saline at pH 7.4. In these experiments 
lyophilized adult stromata, in a concentration of 4 mg per 
ml, completely inhibited equal volumes of anti-I sera with 
an agglutination titer of 256. Cord red blood cell stromata 
at the same concentration inhibited equal ~olumes of anti-
sera with an agglutination titer of 4. 
Neuraminidase treatment. (3.2.1.18 Worthington Biochemical 
Corporation.) 
This enzyme, derived from Clostridium perfrinqens, 
removes N-acetyl neuraminic acid from the terminal ends of 
carbohydrate side chains. 1.0 ml of a 2% suspension of 
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. human group O, Rh negative red blood cells was mixed with 
an equal volume of 0.1 M sodium acetate (ph 5.0), and 0.5 ml 
of 0.05 mg/ml enzyme in saline was added to the mixture. 
The mixture was incubated for 30 minutes at 37°c, followed 
by washing with buffered saline two times. Lyophilized 
stromata at 4.0 mg/ml was treated in a similar way. 
Phospholipase-C treatment (3.14.3. Worthington Biochemical 
Corporation.) 
Phospholipase-C or phosphatidylcholine cholinephospho-
hydrolase prepared from Cl. perfringens catalyzes hydrolysis 
of the linkage between glycerol and phosphate in substrates 
such as lecithin, sphingomylin and phosphatidyethanolamine. 
150 microliters of lyophilized stromata suspension was 
mixed with 200 microliters of 0.1 M Tris-malcate buffer pH 
7.3 and 50 microliters of 0.05 M CaC12 • One hundred micro-
liters of 0.1 mg/ml enzyme in 1% saline solution of bovine 
serum albumin was added and the samples were digested for 
30 minutes at 37°c. The digested membrane particles were 
centrifuged at 50,000g for 15 minutes and both the pellet 
and the supernatent were tested for the presence of the I 
antigen. 
Phosphlipase-D treatment (Calbiochern.) 
This enzyme, prepared from cabbage, digests lecithin 
and other phosphatides liberating choline, ethanolarnine or 
serine. 0.1 ml of lyophilized stromata suspension was mixed 
with an equal volume of 0.1 M sodium acetate buffer (pH 5.6). 
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Ten microliters of 20 mg/ml enzyme suspension in acetate 
buffer and 1 microliter of lM CaC12 solution were added. The 
sample was digested for 3 hours at room temperature. The 
digested membrane particles were washed free of enzyme 
as in the previous treatment. 
Proteolytic enzyme treatment. Trypsin, chymotrypsin, subtili-
sin and pronase. Worthington Biochemical Corporation. 
To 0.1 ml of 4 mg/ml lyophilized membrane fractions 
suspended in 0.1 M Tris buffer pH 8.6, 5 microliters of 
5 mg/ml proteolytic enzymes were added. The samples were 
digested at 370 C for 4 hours and washed with ·· 1% bovine 
serum albumin in buffered saline three timeso 
GlYcosidic enzyme treatment. A crude preparation of glyco-
soidic enzymes from Jack Bean Meal by Dr. E. Eylar, Salk 
Institute, was used in this experiment. The enzyme prepara-
tion was dissolved at a concentration of 5 mg/ml in O.l M 
KCL. To 0.2 ml of lyophilized stroma, 0.1 ml of lM potassium 
phosphate buffer pH 6.5 was added and the samples were 
digested with 0.05 ml of enzyme solution for 10 hours at 
room temperatureo The stromata were washed as before. 
Chemical alterations of the stromata; modification of the 
free amino groups. 
Free amino groups and sulfhydryl groups can be select-
ively blocked by KCNO or acetylated with acetic anhydride. 
0.2 ml of lyophilized stromata dfluted with 0.7 ml of 310 
milliosmolar phosphate buffer (pH 7.4) was reacted with O.l 
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ml of 0.2 M KCNO for five hours at room temperature. A 
similar fraction of 0.2 ml of lyophilized stromata was 
mixed with an equal volume of saturated sodium acetate at 
0 
0 C, and 10 microliters of acetic anhydride was added in five 
equal portions over the course of one hour. After the reac-
tion, the stromata were centrifuged and washed three times 
with buffered saline. 
Periodate destruction of carbohydrates. 
A useful way to specifically destroy certain carbohy-
drates is by periodate oxidation. Under carefully controlled 
conditions, periodate will oxidize simple glycosides with-
out affecting proteins. Lee and Hager (82) successfully 
removed over 90% of the hexoses from chloroperoxidase, a 
glycoenzyme containing approximately 60 residues of hexose 
and five residues of hexosamine, without affecting the 
enzyme activity. The method consists of a mild hydrolysis 
by dialysis at pH 3.5 to break the labilized glycosidic 
bonds. 
Two sets of experiments were performed with periodate. 
In the first set, the stromata were treated with 0.05 M Na 
I04 at pH 4.5 for different lengths of time. 85% of hexos-
amine was destroyed after 6 hours at 20°c under these condi-
tions. Oxidation was stopped by adding excess ethylene 
glycol and the stromata were washed by centrifugation in 
buffered saline. After three washes, no periodate was 
detectable with 1 M KI. For control, stromata were mixed 
so. 
with excess ethylene glycol prior to the addition of NaI04 
and washed immediately. In the second set of experiments, 
oxidation was carried out in 0.04 M · Naro4 for 140 hours at 
4°c, followed by reduction with NaBH4 and hydrolysis at 
pH 3.5. The stromata were washed free of salts using ultra-
filtration and tested for the presence of I-antigen. 
Fractionation of erythrocyte and buffy coat cell membranes. 
Buffy coat cells were obtained through the courtesy of 
Dr. Paul Teresaki of u.c.L.A. Forty units of plasmaphoresed 
blood were used within 12 hours to collect the buf fy coat 
cells and the platelets. Erythrocytes were removed by 
repeated centrifugation in buffered saline. Membrane prep-
arations were obtained by the "Tris-method" of Warren et al. 
{ 83) • 
Red blood cell membrane fractionation was done accord-
ing to Tanner et al. {84), Laico et al. {85) and Ruoslahti 
et al. {86). Membranes were dissociated with 100% formic 
acid prior to enzymatic digestion. Fingerprints were pre-
pared of the trypsin and subtilisin-digested stromata accord-
ing to Katz et al. (87). The solubilized membrane components 
were identified by polyacrylamide gel electrophoresis in the 
presence of sodium dodecyl sulfate (SDS) (88). Protein con-
centrations were determined by amino acid analysis, using the 
Beckman Automatic Analyser. Hexosamine content was determin-
ed according to Rondle et al. (89), and the amount of hexose 
was measured with the anthrone method (90). 
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Molecular fractions obtained after membrane fraction-
ation were tested for the presence of blood group activity. 
Specific inhibition capacity was estimated as follows: 
A dilution of an anti-blood group serum with an agglutination 
strength of 2+ was mixed with an equal volume of the solu-
tion being tested for the presence of blood group activity. 
A decrease in agglutination strength due to inhibition was 
scored and assigned a numerical value . Every drop in agglu-
tination strength on the scale given on p 34 was noted as 
2 inhibition units; for example, a drop from 2+ to + repre-
sents two , inhibition units; to - represents six units. 
These values were then calculated back to a unit concentra-
tion of 1 mg/ml carbohydrate present in the solution being 
tested. Therefore, if a preparation had 0.001 mg/ml hexose 
when it changed an agglutination strength of 2+ to +, the 
2 inhibition units would then be multiplied by 1,000 to 
obtain 2,000 inhibition units per mg of hexose per ml. 
These values have little absolute significance, but they are 
useful for comparative purposes. 
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RESULTS 
THE CHARACTERIZATION OF ANTI-I REAGENTS 
Over thirty sera were screened for the presence of anti-
I cold agglutinins. The final selection was made according 
to the amount of serum available, the agglutination titer and 
the capacity to distinguish between human adult and fetal red 
blood cells. Two chronic cold agglutinin sera and a post-
pneumonia serum were chosen on these bases. In addition, 
serum from a 32 year old Caucasian male who developed cold 
agglutinins following a viral influenza and serum from a 12 
year old Caucasian boy of i blood group type were selected. 
Normal pooled serum was used as control. The concentrations 
of immunoglobulins in these sera were determined and the 
results are summarized in Table 1. All sera will be refer-
red to from here on as indicated in the table. Sera from 
MAY, HOV and COH had six to tenfold increases in macro-
globulin concentration, and three to fourfold decreases 
in 7S gamma globulin as compared with normal pooled serum. 
The amounts of gamma-A immunoglobulins were normal in all 
the sera studied. 
All the sera were tested for their agglutination capa-
city with adult human group A, B and O, Rh positive, and 
group O Rh negative red blood cells and with pooled group 0 
umbilical-cord cells at four different temperatures. The 
results for the three cold agglutinin sera are summarized in 
Figure 4 • The three sera exhibited different agglutination 
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Figure 4. Agglutination characters of the cold agglu-
tinating sera. 
T bl 1 I 1 b 1 . 54. . . h . a e • mmunog o u in concentrations in t e sera studied. 
Patient Diagnosed disease Immunoglobulin concentration: 
mg/100 ml 
IgM IgG IgA 
MAT Chronic cold agglu- 650 300 100 
tinin disease 
HOV Chronic cold agglu- 500 450 150 
tinin disease 
COH Postpneumonia cold 800 300 1000 
agglutinin disease 
DAZ i1 individual, 80 900 115 
thalassemia minor 
AB3 Post viral influenza 140 800 110 
cold agglutinin 
disease 
* NRM Normal pooled serum 80 950 110 
* Hyland Laboratories have published the mean levels of IgM, 
IgG and IgA in normal, white adult to be 80 mg/ioo ml 
(S.D. ~ 29 mg/100 ml), 1200 mg/100 ml (S.D. ~ 319 mg/100 ml), 
112 mg/100 ml (S.D. ~ 41 mg/100 ml) respectively. 
characteristics with respect to temperature. Serum HOV was 
near its maximum agglutination at temperatures as high as 
0 
25 C, the titer for MAT was intermediate at the intermediate 
temperatures, and COH had no significant titer above s0 c. 
No warm-reacting antibodies were found in any of the sera 
when tested at 45°c. The amount of I antigen varies among 
individuals, thus some of the differences observed with cells 
of different blood groups may reflect a variation in I anti-
gen rather than a group specific distinction. Although 
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differences were noted among blood group types, the tempera-
ture profiles were the same for a given serum. 
Red blood cells from the patient COH were tested with 
the serum of MAT and with her own serum. The agglutination 
titers and the temperature responses were identical with 
those given by normal adult group A cells. 
Normal anti-I in an i 1 individual, DAZ, agglutinated I 
positive cells at 37°C and no additional cold acting anti-
bodies were found in this serum.The titer was very low: a 
dilution of 1:3 gave l+ agglutination. The serum from 
patient AB3 with post viral influenza cold agglutinin 
disease had a anti-I titer of 128 at 15°c which increased 
to 256 at s0 c. 
The sera were also tested for additional antibodies 
with other than blood group specificities. A microdroplet 
cytotoxicity test with human lymphocytes was used to detect 
anti-HL-A antibodies. Each serum was tested with three 
different samples of previously typed cells. The results~ 
summarized in Table 2, show that only the post viral 
influenza serum had detectable anti-leuckocyte antibodies. 
This patient's lymphocytes were not available for typing, 
therefore, it is not know if these ·antibodies had auto-
specificities. Serum from DAZ showed positive reaction 
only at 1:2 and 1:4 dilutions with lymphocytes of type HL-A 
2,10,12. Since the undiluted serum failed to show any 
reaction, these results may represent an artifact. Anti-
complementary test were negative for all the sera tested, 
56. 
Table 2. Microdroplet cytotoxicity test for anti-lymphocyte 
antibodies in cold agglutinating sera with anti-I 
specificity. 
Serum Dilution Lymphocyte types 
HL-A 2,12 HL-A 2,10,12 HL-A 2,60 
HOV 1:10 1 1 1 
1:20 1 1 1 
1:40 1 1 1 
COH undiluted 1 1 1 
1:2 1 1 1 
1:4 1 1 1 
DAZ undiluted 1 1 1 
1:2 1 6 1 
1:4 1 4 1 
1:8 1 1 1 
AB3 undiluted 5 6 6 
1:2 6 6 6 
1:4 6 6 6 
1:8 2 6 6 
1:16 1 1 1 
AB3 without 1 1 1 
complement 
The code for scoring cytotoxicity: l= Negative reaction in 
which the viability is the same as in controls. 2= Doubtful 
positive reaction with a perceptible increase in barely 
stained cells over the control level. 4= Doubtful positive 
reaction with slight but detectable change in viability. 
6= Positive reaction, clearly different from controls with 
10 to 90% of the cells killed. 
indicating that the lack of cytotoxicity was not due to some 
serum factor interfering with the detection system. 
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Macroglobulins were isolated from several sera in order 
to make purified IgM cold agglutinins for later experiments 
and for further characterization. Different approaches were 
used for different sera in order to account for the varia-
tions in the most frequent contaminants such as o(. 2-macro-
globulin, j.J -lipoprotein, haptoglobin-2 and aggregates of 
other immunoglobulins. The yields varied according to 
procedures used. 
Small amounts of I-specific cold agglutinins were 
isolated by absorbing the sera with human adult I-positive 
0 
stromata at 5 C for 4 hours. Macroglobulins were eluted at 
37°c after the stromata were washed free of serum proteins 
with cold buffered saline. The eluate was concentrated 
with pressure filtration and passed through a previously 
calibrated Biogel P-300 column. The excluded peak contain-
ing IgM was sometimes contaminated with membrane derived 
aggregates. This however did not interfere with the light 
chain typing of the anti-I macroglobulins. Such prepara-
tions from MAT, HOV and COH indicated the presence of kappa 
type light chains. The yield from AB3 was too low for 
typing and there was not enough serum from DAZ to perform 
the stromata absorption . 
Miller ( 52 ) and Chaplin ( 75 ) suggested euglobulin 
precipitation as a first step for the purification of larger 
amounts of IgM. Euglobulins precipitate when 1 volume of 
serum is mixed with 10 volumes of distilled water, or when 
serum is dialysed against 30 volumes of 2mM- sodium 
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phosphate buffer, pH 8.0, for 24 hours. The euglobulin 
fraction contained all of the serum macroglobulins, 
together with 10-20% contamination of lower molecular weight 
materials and 20-30% of high molecular weight aggregates. 
The most serious disadvantage of this initial step was the 
difficulty of eliminating these nonspecific aggregates. 
Chaplin's approach ( 75 ) of resuspending the euglobulin 
fraction in 1.0 M NaCl 0.5 M tris buffer pH 8.0, followed 
by centrifugation in a 1.065 density salt solution, adjusted 
with NaCl and KBr, was successful in removing the lipoprotein 
and most of the smaller molecular weight contaminants. The 
larger aggregates however had to be separated by ion exchange 
chromatography followed by gel filtration on Sephadex G-200 
columns. This procedure gave a low yield from the serum of 
MAT and the preparation was contaminated with approximately 
15% of larger than 19 S components. 
The best results were obtained when all protein denatura-
tion procedures such as precipitation and lyophilization 
were avoided. Sapharose 4B, Sephadex G-200 and Biogel P-300 
gels were tried for the first step of purification. Both 
Sepharose 4B and Biogel P-300 gels separated IgM from IgG 
but in Sephadex G-200 a considerable overlap was observed. 
A typical elution curve for the COH serum on a Biogel P-300 
column is given in Figure Sa. Portions of the excluded peak 
* were pooled and analysed by immunoelectrophoresis. 
* Rabbit anti-human IgM serum was used to locate the IgM arc. 
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Figure Sb indicates the extent of IgM purification. 
Ion exchange chromatography on DEAE cellulose served as 
a successful additional step of purification . A typical 
elution curve, depicted in Figure 6a, shows the separation 
of IgG, IgA and other contaminants from IgM. The recovery 
varied from 50 to 75% depending on the macroglobulin solubil-
ity in the low ionic strength buffer used for column appli-
cation. If only limited amounts of partially purified cold 
agglutinins were available, sucrose gradient sedimentation 
was a useful procedure for further fractionation. Figure 6b 
indicates the additional separation of the front peak from 
Biogel P-300 gel filtration of serum MAT. The major peak 
had a sedimentation of 19S and showed a single band for IgM 
by immunoelectrophoresis. 
None of the above methods resulted in a pure IgM prepara-
tion from nor~al serum, therefore an additional step of 
starch-block electrophoresis was introduced . The macroglobulin 
fraction obtained by gel filtration and DEAE ion exchange 
chromatography was electrophoresed in 0 . 2 M borate buffer 
pH 8.6 using starch as a supporting medium. After the 
separation 1 cm blocks were cut out and eluted. Figure 7 
shows the results and the extent of purification as indicated 
by immunoelectrophoresis. The final yield was between 8 and 
10 mg macroglobulin from 100 ml of normal serum. This repre-
sents a 10-12% recovery. The yield from cold agglutinin sera 
varied with the number of purification steps used. 60-75% 
of recovery of IgM preparations with better than 80"fe purity 
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was obtained from the sera of COH, HOV and MAT. 
Purified cold-agglutinins behaved like the sera from 
which they had come in agglutinating human adult red blood 
cells of the various ABO groups and their stromata. The 
temperature profiles were also similar. Mild treatment with 
beta-mercaptoethanol dissociates IgM molecules into five 
subunits ( 52 ). These subunits failed to agglutinate 
erythrocytes even at ten times the concentrations necessary 
for agglutination by the intact macromolecule. 
IgG obtained from the sera of HOV and COH after DEAE 
cellulose ion exchange chromatography failed to agglutinate 
cells at concentrations of 3 mg/ml. Both Coombs and comple-
ment-binding tests were negative, indicating that the !-
specific agglutination system depends on 198 antibody reac-
tions and does not involve IgG. 
IgM from the postpneumonia cold agglutinin serum of COH 
was purified by disc gel electrophoresis and immunoelectro-
phoresis as indicated in Figure 9a., the heavy and light 
chains were separated after reduction of the disulfide 
bonds withdithiothreitol and alkylation with ethylenimine. 
The fractionation on a previous.ly calibrated Sephadex G-200 
column in 5 M guanidine hydrochloride is depicted in Figures 
8,9 • The light chains failed to react with rabbit anti-
human lambda serum at a concentration of 3 mg/ml. Their 
amino terminal sequence and the sequence of normal pooled 
human light chains are given below. Serine and threonine 
are together assigned the symbol "Xoh", because they were 
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not distinguishable using thin plate chromatography. 
Normal human light chains: 
Asx-Ile-Val-Met-Xoh-Glx-Xoh-Pro-Xoh-Xoh-Leu-Xoh--
Glx Glx-Leu 
Light chains from COH IgM: 
Asx-Ile-Val-Met-Xoh-Glx-Xoh-Xoh-Leu-Xoh-Leu-Xoh--
The light chains from COH IgM belong to the kappaII 
subclass reported by Gray et al ( 99 } . Absence of lambda 
chains in the IgM preparation and single amino acid at 
each of the three positions in the sequence at which there 
are two alternatives in a normal pooled sample suggest that 
the cold agglutinin is a homogeneous monoclonal product 
or that it has a very restricted heterogeneity. The 
results also indicate that over 80% of the IgM globulin, 
the limit of detection in this system, is I-specific cold 
agglutinin in the serum of COH. 
6 7. 
THE DEVELOPMENT OF THE I ANTIGEN 
Two significant changes in postnatal erythrocyte 
development were studied; one was the development of the I 
antigen and the other was the rate of adult hemoglobin 
appearance. The arrangement for obtaining samples made it 
impossible to follow the same inf ant from birth on; there-
fore, the study was carried out on separate individuals. 
Umbilical cord blood samples and postnatal infants' samples 
were ABO typed and the percent of fetal hemoglobin was 
determined using alkali denaturation. The percent of "I 
negative" cells was determined for all the blood samples 
studied and the results are summarized in Table 3 "I 
negative" cells were defined as the portion of erythrocyte 
population which fails to agglutinate with anti-I sera 
diluted to 32 times the minimal concentration necessary to 
produce complete agglutination of adult I-positive cell 
suspension . 
Agglutination titers with anti-A and anti-I (from HOV) 
sera were determined for the "I negative", "I positive" 
subpopulations and for the unfractionated cells. Two charac-
teristic examples of infants' cells are, summarized in Table 
4 • Normal adult I cells all agglutinate under these 
conditions; the table therefore gives only the results for 
"I positive" adult cells. Quantitative differences were 
observed in I-agglutinability of the two subpopulations of 
cells which indicates that fractionation has been achieved. 
However, the term "I negative" is used only for convenience 
68. 
Table 3 • Blood samples of postnatal infants characterized 
with respect to ABO type, fetal hemoglobin content, 
and percent of "I negative" cells. 
Age in days Blood Percent of HbF Percent of 
after birth group in red blood "I negative" 
cells cells 
H cord cells 0 50 58 
H cord cells 0 64 84 
43 A2B 49 47 
45 Al 62 61 
51 0 38 71 
57 Al 30 78 
70 0 24 21 
75 0 40 23 
80 B 21 24 
87 Al 18 18 
88 Al 17 18 
89 Al 26 9 
105 Al 40 81 
107 Al 14 34 
114 Al 17 58 
117 0 5 8 
124 0 6 5 
127 B+ 3 54 
159 0 5 11 
174 A1B 4 20 
185 A1B 10 49 
210 A1B 11 22 
352 0 2 5 
Adult Al 2 0 
Adult Al 2 0 
69. 
Table 4~. Characteristic behavior of cells before and after 
fractionation with respect to their agglutin-
ability with anti-A and anti-I sera. 
Sample Cell Antis era Dilutions of antisera 
population 2 4 8 16 32 64 128 256 512 
A.C. 
male 
age: 
2 mos. 
A1 , I, 
Rh+ 
unfrac-
tionated 
"I 
positive" 
"I 
negative" 
unfrac-
tionated 
"I 
positive" 
"I 
negative" 
anti-A 2+ 2+ 2+ 
anti-I 3+ 3+ 2+ 
anti-A 3+ 2+ 2+ 
anti-I 3+ 3+ 2+ 
anti-A 2+ 2+ 2+ 
anti-I 2+ + + 
anti-A 2+ 2+ 2+ 
anti-I 3+ 3+ 2+ 
anti-A 3+ 2+ 2+ 
anti-I 3+ 3+ 2+ 
anti-A 2+ 2+ 2+ 
anti-I 2+ + + 
+ + :j: * 
+ + + =!= 
+ + 
+ * 2+ 2+ 
+ * 
+ + 
+ * 
+ + 
+ + 
* * + + 
+ * 
+ + 
+ * 
2+ 2+ 
+ * 
+ + + :j: 
+ + * 
* 
J.G. 
male 
Age: 
unfrac- anti-A 2+ 2+ 2+ + + + ::f 
~------~----~-------------------'---------~ 
tionated anti-I 2+ + + * + :j: * 
"I anti-A 2+ 2+ 2+ + + + :f 4 mos. 
A1 1 I 
~------------~----------------------------~ positive" anti-I 2+ 2+ 2+ 2+ + * 
Rh+ "I anti-A 2+ 2+ 2+ + + + * 
--~----~------~----~------~------------~ 
negative" anti-I 2+ + + 
* Z.T . unfrac- anti-A 3+ 3+ 3+ 2+ 2+ 2+ + :f 
male 
normal ___ t_i_·o_n __ a_t_e_a ____ a_n __ t_i_-_I ____ 3_+ ___ 3_+ __ 3_+ ____ 3_+ __ 3_+ __ 2_+ ____ +____ + ____ :f~ 
adult "I anti-A 3+ 3+ 3+ 2+ 2+ + + 
~h · ~ positive" anti-I 3+ 3+ 3+ 3+ 2+ 2+ + + 
* 
Legend for Figure 10, page 71. 
The absolute values obtained for the HbF content appear to be lower 
than the values reported in the literature . This may be due to the 
difference in the methods used. As a result of it, the curve indicating 
the decrease in % JmF in the whole blood may have shifted, but would not 
differ significantly in i ts character. 
Similarly the absolute values obtained for the number of Hb molecules 
per single erythrocyte cell are higher by a factor of three. This di f ference 
is probably due to artifacts caused by the cell fixation to the quartz 
slides, but will not affect the conclusions drawn with respect to the rate 
of decrease in HbF' content in postnatal infants. 
70. 
in describing the cells that fail to agglutinate under the 
specified conditions. Anti-I sera diluted to 32-64 times 
the minimal concentration necessary to produce complete 
agglutination of adult I cell suspension seemed to be the 
most promising for cell fractionation. Less diluted sera 
would give a lower percent of "I negative" cells, which in 
many instances would result in a shortage of cells to work 
with. Many of these cells actually have some I antigenic 
sites · on their surfaces and have a limited capacity to 
absorb anti-I antibodies. 
The fractionation with anti-I cold agglutinins did not 
interfere with the A-agglutination. Both fractions had 
the same agglutination titer with anti-A serum as did the 
unfractionated cell population. No difference was observed 
between the two subpopulations with respect to the A 
antigen. Does this mean that the A antigen is evenly 
distributed on the cells of these two subpopulations? This 
question was further studied with r 125-labeled anti-A 
antibodies and will be discussed later. 
The rate of adult hemoglobin appearance and the rate 
of disappearance of "I negative" cells as a function of age 
are summarized in Figure 10 • The results show a much 
greater variation in the appearance of "I positive" cells 
than in the disappearance of HbFo At an age of 120 days a 
variation as high as 45% was observed, whereas the ·greatest 
variation in HbF was on the order of 20%. The percent of 
HbF as a function of the percent of "I negative" population 
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is indicated in Figure 11 • Two hypothetical relationships 
are also indicated in this graph. In one case if the two 
events were closely associated in a one to one proportion 
with 20"/o deviation allowed, the values should have fallen 
between the two dotted lines. For example, blood with 10% 
+ 
of "I negative" cells would have 10- 2 % HbF and 30"/o of "I 
negative" cells would have 302:° 6% HbF. The mean values 
would lie on a straight line with a slope of 1. In the 
second case a two to one proportion is assumed; blood 
with 10"/o of "I negative" cells would have 5.:!:° 1% HbF, and so 
on. The values should fall between the two solid lines in 
this case, and the straight line of the mean values would 
have a slope of 0.5. Slopes of less than 1 would indicate 
that the appearance of HbA takes place prior to the expres-
sion of I antigen and a slope of greater than 1 would mean 
that the I antigen expression precedes the biosynthesis of 
HbA. As the figure indicates, the observed values do not 
fall into either hypothetical category with 20% deviation, 
thus there is no evidence of close association between the 
two processes. 
To further test the above conclusion fetal and adult 
hemoglobin contents were determined in the postulated two 
subpopulations of cells. The results are summarized in 
Table 5 Similar values were obtained using ion exchange 
chromatography on IRC-50 resins. Three of ten samples, at 
scattered postnatal ages and with no sign of a trend in 
time, showed significantly more fetal hemoblobin in the 
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cell fraction defined as "I negative" t h an in the fraction 
defined as "I positive". The HbF content can vary from 8"/o 
to 90"/o in "I negative" cells and can be as high as 83% in 
"I positive" cells. These results are consistent with the 
previous indication that the two developmental processes 
are not closely associated . 
Table 5 The percent of HbF in the cells fractionated 
according to their agglutinability with anti-I 
* cold agglutinins~ 
Age of postnatal 
inf ant in days 
Percent of Fetal hemoglobint in 
"I positive" cells "I negative" cells 
1 
45 
51 
57 
75 
89 
105 
114 
127 
185 
Adult 
83 + 8 
42 + 4 
42 + 4 
29 + 4 
+ 30 - 5 
21 ± 5 
52 ~ 4 
15 + 5 
+ 5 - 2 
+ 14 - 3 
3 + 1 
90 + 8 
60 + 5 
+ 40 - 4 
+ 30 - 4 
70 + 6 
56 + 9 
54 ~ 6 
20 + 4 
8 + 2 
+ 22 - 4 
* The amount of HbF was determined by the alkali denatura-
tion method . 
t ~esults are the mean values with standard deviations 
calculated from three separate determinations. 
All of the preceding experiments were performed on 
pooled cells. The amounts of hemoglobins present in single 
7 5. 
cells were determined as a further extension of this study. 
At the outset an attempt was made to identify "I positive" 
cells with the help of fluorescein tagged anti-I IgM 
molecules, followed by a microspectroscopic determination 
of the kinds and amounts of hemoglobins present inside the 
cell. Successful staining was achieved with a "sandwich 
technique" using labeled human anti-I IgM and tagged rabbit 
anti-human IgM molecules. However, the hemoglobin contents 
of these cells .could not be determined because. of extensive 
lysis and cell degradation in the fixing procedure. The 
only method found successful in distinguishing cells with 
respect to their I antigen expression was the agglutination 
of cells with undiluted anti-I sera on a quartz slide. In 
this manner only the unagglutinated 11 I negative" single 
cells could be used for hemoglobin characterizations. Any 
dilution of the anti-I sera resulted in an uneven drying of 
the cells with frequent cell rupture. 
The absorption spectra of single erythrocytes were 
similar to the spectrum of oxyhemoglobin in solution. The 
maximum absorption peak was at 415 mp, the wavelength at 
which all the measurements were performed. Extraction with 
low pH buffer did not change the spectrum, indicating that 
hemoglobin was qualitatively unchanged by this procedure. 
Using the absorption coefficient of 124 per millimole of 
heme at 415 mu wavelength, the number of hemoglobin mole-
cules per cell was calculated to be 3 x 108 • Measurements 
on a single cell had a standard deviation of ~ 5.1%. 
76. 
Figure 12 shows the optical absorption for 100 adult and 
100 umbilical cord cells. After extraction with low pH buf-
fer the absorption decreased as indicated. Cord cells con-
tained 65% HbF and adult cells less than 3% as determined 
by alkali denaturation. The mean of 0.297 for the adult 
cells decreased to 0.096 as a result of extraction for 20 
seconds. This amounts to the removal of 68"/o of the HbA. 
Over 800/o of the HbA was removed during a 40 second treat-
ment; however, it became increasingly difficult to locate 
and to focus on cells as less hemoglobin remained on the 
slide. 
Cord cells had a mean absorption of .287, which 
decreased to .199 after extraction for 20 seconds. This 
corresponds to a 31% loss in hemoglobin content. The differ-
ence between the adult and cord cells is due to the insolu-
bility of HbF in the low pH buffer. Any possible interfer-
ence from cell membranes can be ruled out on the basis of 
the work by Betke and Kleihauer 98 ) • They extracted 
known mixtures of hemoglobin solutions from filter papers 
and demonstrated that the a~ount eluted was directly propor-
tional to the HbA concentration. 
99% of the adult cells had an optical absorption of less 
than .160 after the extraction. Approximately 10-15% of the 
cord cells fall into this category, indicating that only in 
this proportion of cells is the hemoglobin essentially all 
HbA. Blood samples containing only HbF were not available, 
therefore it is difficult to identify cells which contain 
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HbF exclusively. An optical absorption of .250 or higher 
after extraction for 20 second can be classified as belong-
ing to cells containing mainly fetal hemoglobin. This would 
amount to about 10% of the population in cord blood; the 
remainder of the cells would contain varying amounts of HbA 
and HbF. The results confirm previous observations on the 
absence of two distinct populations of cells containing 
exclusively HbA or HbF. If there were two clearly distinct 
populations, one would expect that 32% of the cells would 
have given optical absorption of less than .160, and the 
remainder would be unaffected by the extraction. Such 
results were not found in any samples from umbilical cord 
or from postnatal infants. 
In order to study the hemoglobin content of "I negative" 
cells, certain controls were necessary to find out if frac-
tionation was achieved. Equal mixtures of adult and cord 
cells with and without anti-I serum were fixed on quartz 
slides. Figure 13 shows the results. Adult and cord 
cells were indistinguishable prior to extraction. A 
bimodal distribution with some overlap was obtained follow-
ing extraction. If successful fractionation is achieved 
with anti-I serum, the single unagglutinated cells 
designated as "I negative" should resemble the cord cells 
after low pH treatment. The results shown on Figure 1 3 
confirm that "I negative" cord cells are separated from 
"I positive" adult cells in a mixture by the fractionation 
procedure. Approximately 15-20% of the "I negative" cells 
(}) 
G) 
15 
10 
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Adult and cord cells before extraction 
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o Adult and cord cells after extraction 
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.I 00 .200 .300 .400 
11 I negative11 cells from adult 
and cord cells ofter extraction 
. 
. . . . . 
. . . . . .. 
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.I 00 .200 .300 .400 
Optical Absorption at 415 mµ 
Figure 13. Fractionation of a mixture of adult and 
cord red blood cells with anti-I serum 
(HOV) and the determination of their 
hemoglobin content. 
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possessed only HbA . Since normal cord cells contain 10-15% 
such cells, the results indicate that only about 5% adult 
11 I positive" cells contaminate the portion of the cells 
designated and fractionated as "I negative". 
Results for two representative blood samples from 
infants studied in this manner are summarized in Figures 14 
and 15 • Blood from Acuna and Xavier contained 14% and 
8.7% HbF respectively. None of the samples had any cells 
containing HbF exclusively , as determined from the optical 
absorptions of the unfractionated cells following extraction. 
HbF was always present with different proportions of HbA in 
the same cells. The 11 I negative" cells contained insignifi-
cantly higher amounts of HbF . This subpopulation also 
included cells containing HbA exclusively. These results 
prove that the expression of the I antigen is independent 
of the hemoglobin content of the cell during postnatal 
development. 
The relationship between the development of I and ABO 
antigens was further pursued. The rate of A and I antigen 
expression was studied with r 125-labeled anti-A immuno-
globulins from immunized human sera . This method has been 
used successfuly to study the distribution of ABO and Rh 
antigens on the red blood cell surface . It is assumed that 
the amount of antibody absorbed is a direct indication of 
the number of antigenic sites available . The success of the 
experiment lies in the binding specificity and strength of 
the antibody used. The labeling procedure can alter the 
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Figure 14. Hemoglobin content of single red blood 
cells. Patient: Acuna, female, 
Caucasian, age: 4.5 months. Fetal h~~o­
globin content: 14%. ,;I negative" cells: 
33%. Blood Group: O,I, Rh+o 
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Figure 15. He...~oglobin content of single red. blood cells. 
Patient: Xavier, female, Caucasian, age: 9 
months. Fetal hemoglobin content: 8.7%. 
Blood group: A1 , I, Rh+. 
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binding capacity unless it is carried out under very mild 
conditions. The "hypochlorite method" developed by 
Greenwood ( 81 ) proved to be the most useful. Each prepara-
tion of labeled antibodies was absorbed using type A or 0 
cells to eliminate most of the nonspecific binding. 
Specific absorption was greatly improved after the cells 
were formaldehyde treated, which also helped to minimize 
lysis caused by washing procedures. 
Two different approaches were used to determine the 
number of antibodies absorbed to the cells. The more conven-
tional approach is to elute antibodies for scintillation 
counting at slightly elevated temperatures of 45-50°c. This 
elution is never complete, indicating that significant 
amounts of antibody remain firmly bound to the cell surface. 
Data for experiments I, II and III summarized in Table 6 
were obtained by this method_ In the other · approach, used 
in experiment IV, cells with absorbed antibodies were solubi-
lized together and the amount of radioactivity determined. 
Unreasonably high values were obtained this way, but the 
difference between the two subpopulations of cells remained 
comparable to the results of the previous experiments. The 
number of I 125-labeled anti-A IgG molecules per group A 
cell was calculated after subtracting nonspecific absorption 
to group 0 cells. 
Umbilical cord cells were studied in experiment I. 
The number of A-antigenic sites was approximately 30,000 
per cell. This is about the lowest limit of determination 
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85. 
with this method. Standard deviations as high as 21% made 
it impossible to detect any significant difference between 
the "I negative and positive" cell populations. Adult cells 
exhibited a tenfold increase in the number of antigenic sites. 
Erythrocytes from postnatal inf ants were studied in 
experiment II and III. Although all samples indicated 
higher numbers of A antigenic sites on "I positive" cells, 
only two out of four were statistically significant. Separ-
ate batches of labeled antibodies were used in these experi-
ments and they accounted for the differences observed in 
the values for the adult cells . Cells which had not been 
treated with anti-I cold agglutinins were included in both 
experiments. They served as controls for any interference 
from cell fractionation, such as steric hindrance due to 
unremoved anti-I IgM molecules. A 10% decrease in both 
experiments following cold agglutination indicated minimal 
interference. 
The values obtained in experiment IV were tenfold 
higher than in the previous experiments due to the differ-
ent method used to measure absorbed radioactivity. The 
percent difference between the two cell populations was 
however, of the same order as in the previous determinations. 
This indicates that there was no artifact due to the elution 
technique used to evaluate the amounts of labeled antibody 
molecules absorbed to the two subpopulations of cells. 
86. 
CHEMICAL AND ENZYMATIC ALTERATIONS OF HUMAN ADULT STROMATA 
AND THEIR EFFECTS ON THE I ANTIGEN. 
Modifications of I antigen can be demonstrated by the 
elimination of inhibition capacity of I positive stromata 
in the agglutination system of anti-I cold agglutinins and 
human adult erythrocytes. In all the following experiments, 
serum from HOV was diluted into samples containing altered 
and washed stromata suspensions. Untreated human adult and 
umbilical cord cell stromata were used as controls. The 
results of several experiments are summarized in Table 7 
Two reagents, KCNO and acetic anhydride, capable of 
reacting with free amino groups, failed to alter the I anti-
gen. Lyophilized stromata treated with these reagents absorb-
ed anti-I IgM molecules to the same extent as the untreated 
samples. The partial destruction of neuraminic acid by either 
0.2 N H2so4 or by neuraminidase treatment also failed to 
eliminate the specific absorbing capacity of the stromata. 
No detectable effect was seen as a result of phospholipase 
treatment. Pronase treatment lysed the test cells, so no 
conclusions could be drawn. Partial digestion with trypsin 
and chymotrypsin failed to eliminate the inhibition capa-
city of the stromata. Prolonged treatment with proteolytic 
enzymes disrupted the stromata. The undigested membrane 
pieces, sedimented by centrifugation, had no anti-I absorp-
tion capacity. The supernatant was tested for released 
inhibiting activity, but again considerable lysis occured. 
This was probably due to lecithin, known as a lytic agent, 
87. 
Table 7 • Inhibition of anti-I serum from HOV with human 
I positive stromata before and after chemical 
and enzymatic modifications. 
Additions to the 
serum, treatment 
of stromata 
No addition 
Lyophilized 
stromata 
KCNO 
AC.ANH. 
0.2N H2so4 
NaI04 (17 hrs) 
Lyophilized 
stromata 
Glycosidic Enz. 
* from J.B.M. 
Neuraminidase 
Phospholipase-C 
Phospholipase-D 
Pronase 
Lysozyme 
Cord RBC 
stromata 
No addition 
Dilutions of Anti-I serum 
2 4 8 16 32 64 128 256 512 1024 2048 4096 
+ + + + + + + 
+ + + I 
+ + + + I I 
+ + + 'I 
+ · + + + 'I 'I 
+ + + + + + + 
+ + + I I 
+ + + + + + + 
+ + + 'I I 
+ + + + I 'I 
+ + + + I 
+ f L L L L L 
+ + + + 'I 
+ + + + + + + 
+ + + + + + + 
+ + + 
+ 
L 
+ + + 
+ + + 
Agglutination was scored as follows: + =well defined agglu-
tination; I = weak, partial agglutination; - = no observable 
cell clumps; L = lysis. 
* Jack bean meal 
88. 
liberated from the membrane. 
Crude preparation of glycosidic enzymes from jack bean meal 
gave pronounced destruction of I antigen, quantitatively 
similar to the destruction of I antigen by periodate oxida-
tion to the polyaldehyde form. The alteration of A and I 
antigens by periodate oxidation was further studied in 
experiments in which the polyaldehyde products were reduced 
with NaBH4 to their corresponding polyalcohol forms and the 
labile glycosidic bonds were cleaved by mild acid hydrolysis. 
42% of the membranes' carbohydrate was oxidized in this 
procedure, as measured by the Anthrone method. The concen-
trations of the treated and the untreated stromal samples 
were adjusted to the same protein concentrations. The 
results for the antigen degradation are summarized in Table 
8 • In these experiments, the antisera were diluted to 
give an agglutination strength of 2+ and then mixed with 
samples of serially diluted stromata. If the stromata had 
no capacity to absorb anti-I igM the agglutination would 
remain 2+ in all the dilutions. The untreated stromata 
could be diluted 640 times to inhibit the anti-I serum, 
whereas after the periodate treatment a forty-fold dilution 
was needed to cause comparable inhibition. Anti-B serum 
was used as a control to test for nonspecific binding to 
A positive stromata. 
89. 
Table 8 Tests for alteration of A and I antigens on human 
* adult stromata by periodate oxidation. 
Antisera dilutions Test 
cells 
Untreated stromata 
Anti-A serum 1:200 
Anti-B serum 1:120 
Per iodate treated 
stromata 
Anti-A serum 1:200 
Anti-B serum 1:120 
Untreated stromata 
Anti-I serum 1:125 
Periodate treated 
stromata 
Anti-I serum 1:125 
A1 I 
B I 
A1I 
BI 
Agglutin- Dilutions of A2I stroma 
at ion 
without 
stroma 
1 2 4 8 16 32 64 
2+ f f + 2+ 2+ 2+ 
2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
2+ + + + 2+ 2+ 2+ 
2+ 1.5+ 2+ 2+ 2+ 2+ 2+ 2+ 
20 40 80 160 320 640 1280 
2+ 2+ 
2+ f + + + 2+ 2+ 
* Stromata were prepared from human adult A2,I erythrocytes. 
50 microliters of diluted antiserum was mixed with 50 micro-
liters of serially diluted stromata suspension in buffered 
0 
saline, incubated for two hours at 4 C and the unabsorbed 
cold agglutinins were tested for with 50 microliters of 
fresh human adult type A or B cells. Agglutination was 
scored as previously described, after an additional hour of 
incubation at 4°c. 
90. 
FRACTI ONATION OF ADULT AND UMBI L I CAL CORD RED BLOOD CELL 
MEMBRANES WITH RESPECT TO THE LOCALI ZAT I ON OF THE I ANT IGEN. 
Adult and cord erythrocyte membranes were digested with 
trypsin and subtilisin for fingerprinting. This method was 
used as an initial test to determine if there was any detec-
table difference between the two preparations. The quality 
of fingerprints improved if the membrane preparations were 
denatured and lipids were removed by chloroform-methanol 
extraction prior to digestion. Lyophilization after concen-
trated formic acid treatment was used for disrupting the 
stromata. The tryptic fingerprints so obtained are repro-
duced on Figure 15 • The major peptides visible are from 
the 11 miniprotein 11 component of the stromata demonstrated by 
Laico et al ( 85 ). No differences are observed on the 
fingerprints obtained after trypsin or subilisin digestion. 
This indicates that proteins of cord and adult erythrocyte 
membrane which are present in 100/o or h igher molar amounts 
are id.en ti cal. 
Previous procedures to isolate molecular fractions with 
blood group activity have started with extraction with 
various mixtures of organic solvents. The insoluble protein 
aggregates formed as a result of the extraction are discard-
ed. These aggregates do not show ABO ·or I activity , but in 
our hands digestion with trypsin revealed blood group acti-
vity. Since digestion did not destroy the ABO and I 
activity of the stromata, experiments were performed to 
locate on the fingerprints molecular fractions responsible 
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92. 
for them. The advantage of this approach is in having all 
the membrane materials present with no fractions discarded. 
Denatured stromata were trypsin digested and applied 
to Whatmann 3MM filter paper in a streak using approximately 
2 mg stromata per centimeter. The sample was chromatograph-
ed with the organic phase of the mixture of n-butanol: 
acetic acid water ; 4:1:5 until the solvent front moved 
to the end of the paper. The dried paper was divided into 
five equal strips and the peptides eluted. The fractions 
were designated according to their characteristic Rf values, 
defined as the relative rate of migration with respect to 
the solvent front. The distribution of blood group activity 
is summarized in Table 9 The most hydrophilic fraction 
Rf 0.0-0.2, and the most hydrophobic fraction, Rf 0.8-1.0 
were the only ones with blood group activity. 
The hydrophobic fraction contained all the neutral 
lipids and a small number of peptides with high amounts of 
leucine, isoleucine and valine. In addition, 1-1.6% carbo-
hydrate by weight was present as determined with the 
anthrone method. The presence of A or B blood group activity 
in this fraction was always marginal or questionable 
because of the very high nonspecific inhibition presumably 
by lipids which coat the test erythrocytes. No I antigen 
activity was ever found even in concentrations of 10 mg/rnle 
The eluate from the hydrophilic region, Rf 0.0-0.2, 
was paper electrophoresed at pH 1.7. The results of the 
fractionation and the distribution of blood group activity 
Table 9 
Samples 
Rf 0.0-0.2 
Rf 0.2-0.4 
Rf 0.4-0.6 
Rf 0.6-0.8 
Rf 0.8-1.0 
Control 
93. 
The distribution of blood group activity follow-
ing chromatography of typsin-digested type B,I 
* stromata. 
Anti-sera 
Anti-B 
Anti-A 
Anti-I 
Anti-B 
Anti-A 
Anti-A 
Anti-B 
Anti-A 
Anti-I 
Anti-B 
Anti-A 
Anti-I 
Anti-B 
Anti-A 
Anti-I 
Anti-B 
Anti-A 
Anti-I 
No addition 
2+ 
3+ 
2+ 
2+ 
3+ 
2+ 
2+ 
3+ 
2+ 
2+ 
3+ 
2+ 
2+ 
2+ 
3+ 
2+ 
l+ 
3+ 
Dilution of samples, 
2 mg/ml 
0 2 4 8 16 
I 
2+ 2+ 3+ 
I 
l+ 2+ 2+ 2+ 
2+ 3+ 3+ 3+ 
l+ 2+ 2+ 2+ 
2+ 2+ 2+ 2+ 
2+ 3+ 3+ 3+ 
2+ 2+ 2+ 2+ 
2+ 2+ 2+ 2+ 
2+ 3+ 3+ 2+ 
2+ 2+ 2+ l+ 
-I + l+ 
I -I -1 l+ 
2+ 3+ 3+ 3+ 
2+ 2+ 2+ 2+ 
l+ l+ l+ l+ 
3+ 3+ 3+ 3+ 
l+ 
3+ 
+ 
2+ 
3+ 
2+ 
2+ 
3+ 
2+ 
2+ 
3+ 
2+ 
2+ 
2+ 
3+ 
2+ 
l+ 
3+ 
* The control was the eluate of an unused filter paper strip 
equal in size to the samples. Agglutination was scored 
as described in Methods section. An attempt was made to 
dilute all the antisera to the same agglutination strength, 
but some variation was unavoidable. 
94 . 
lo 9 8 7 6 5 4 3 2 / 1 I 
origin 
ninhydrin-
staine d 
peptide 
bond-
stain ed 
,. 
eluted 
0 fractions 
Inhibition of anti-A, anti- B and anti- I (HOV) ser a by the 
eluted fractions e 
anti- A serum I anti- B serum I anti-I serum 
dilution of the fractions 
Fractions 1 2 4 8 16 1 2 4 8 16 1 2 4 8 16 
0 :/ I + 1+ 2+ I + 2+ I 1+ 
1 t- + l+ 2+ 2+ :/ + 1+ 2+ t- 1+ 
2 1+ 2+ 2+ 2+ 2+ + l+ 2+ 2+ 2+ + 2+ 2+ 2+ 2+ 
3 2+ 2+ 2+ 
4 2+ 2+ 2+ 
5 2+ 2+ 2+ 
6 2+ 2+ 2+ 
7 2+ 2+ 2+ 
8 2+ 2+ 2+ 
9 2+ 2+ 2+ 
10 2+ 2+ 2+ 
Control 2+ 2+ 2+ 
Figure 16e Electr ophore sis of the hydrophilic fraction 
from subtilisin digested human adult B,I stromata . 
95 . 
following elution are summarized in Figure 16. The two 
samples with A,B and I activity contained approximately 
equal amounts of carbohydrate and amino acid by weight. 
Both fractions were rich in serine and threonine and 
contained 30-40 mole-percent hexosamine. Ser, asp, glu and 
ala were the amino acids labeled with densyl chloride after 
amino terminal analysis, indicating considerable peptide 
heterogeneity. 
In order to compare the amount of I blood group activity 
present in dif terent membrane preparation, the chromatography 
step alone was satisfactory . Two such comparisons were made. 
Adult red blood cell stromata were compared with cord cell 
stromata and with buffy coat membrane preparations. 
Stromata from pooled cord blood samples and lyophi-
lized adult, I positive, stroma were dried to constant 
weight. Both samples contained 2.7 ~ 0.2% carbohydrate and 
48 ! 2% proteine Adult stromata absorbed 64 times more 
anti-I specific cold agglutinins than the stromata from 
cord cells. 
After chromatography of subtilisin-digested samples, 
the hydrophilic fraction represented 4-5% and the lipophilic 
material 35-45% of the stromatal dry weight . The relative 
amounts of anti-I inhibiting capacity determined from the 
hydrophilic fractions are summarized below. 
Adult: 1500 inhibition units/mg of hexose in the stromata 
94 inhibition units/mg of protein in the stromata 
40 inhibition units/mg of stroma.ta 
96. 
Cord: 850 inhibition units/mg of h e xose in the stromata 
49 inhibition units/mg of protein in the stromata 
25 inhibition units/mg of stromata 
Inhibition units were calculated from the decrease in Sanger 
agglutination units and end-point dilutions as described in 
Matierals and Methods section. 
Similar comparisons were made with membranes of buffy 
coat cells. The results are summarized in Table lo. Hydro-
philic fractions from both trypsin and subtilisin digestions 
of adult stroma were able to inhibit anti-I sera diluted to 
an agglutination titer of 2+, at a concentration of 0.16 mg/ 
ml. The same fraction from buffy coat cells failed to 
inhibit, or showed only marginal inhibition at 5 mg/ml con-
centration. If the I antigen-carrying molecules are the 
same in every membrane , these results indicate that there 
are 30 times less I-specific molecules in the membranes of 
buffy coat cells. This is in agreement with the observation 
that leukocytes from pooled blood samples failed to agglu-
tinate with undiluted anti-I sera of HOV and COH and is also 
consistent with the negative cytotoxicity tests with 
chronic cold agglutinin sera. 
Erythrocyte membrane fractionation was further pursued 
in order to isolate molecules with I antigen specificity 
and to further study the relationship between ABO and I 
blood group specificity. These experiments reflect the 
efforts in Dr. Dreyer's laboratory to develop techniques 
for membrane fractionation. The work was done in 
97. 
Table 10 The inhibition of anti-I cold agglutinins (HOV) 
by hydrophilic fractions prepared by chromato-
graphy of trypsin and subtilisin digested mem-
brane preparations. 
Sample 
Dilutions 
Hydrophilic fractions prepared 
RBC stromata Buffy coat Buffy coat 
from: 
RBC stromata 
subtilisin 
digest 
tryptic cell tryp- cell sub-
digest tic digest tilisin 
digest 
5.0 mg/ml 2+ l+ 
diluted 1:2 2+ 2+ 
diluted 1:4 2+ 2+ 
diluted 1:8 2+ 2+ 
diluted 1:16 2+ 2+ 
diluted 1:32 
-f 2+ 2+ -f 
diluted 1:64 l+ 2+ 2+ l+ 
No additions 2+ 2+ 2+ 2+ 
50 microliters of anti-I serum, diluted to an agglutination 
strength of 2+, were mixed with 50 microliters of sample; 
incubated for 4 hours at 4°C. Anti-I agglutinins not 
inhibited by the sample were tested for with 50 microliters 
of 2% adult,I red blood cell suspension. 
collaboration with Dr. M. Tanner and Dr. E. Ruoslahti. 
Preliminary fractionations were done according to Tanner, 
Gray and Dreyer ( 84 ) • Treatment of stromata with 0.1 M 
EDTA (Na2 ) failed to solubilize the I-antigen. Lipid 
fractions obtained by 900/o 2-chloroethanol or with chloroform-
98. 
methanol extraction did not have any capacity to inhibit 
anti-I cold agglutinins. Stromata from which lipids had 
been removed were partially solubilized in SM guanidine 
hydrochloride, reduced and aminoethylated. The samples 
were centrifuged to remove insoluble aggregates and to 
separate the floating lipoprotein layer. Both of these 
fractions displayed marginal ABO and I blood group activity. 
The dissolved membrane components were further separated on 
a Sephadex G-200 column in SM guanidine hydrochloride, 
but none of the fractions obtained had any capacity to 
inhibit anti-I, anti-A or anti-B sera. 
Successful stromal fractionation was achieved using a 
procedure developed by Ruoslahti (86). Human adult B,I 
stromata were stirred for an hour in 100% formic acid at 
4°c. Recrystallized urea was added to make the concentra-
tion 10 molar. The final solution in 2S% formic acid and 
10 M urea was chromatographed on a SE-Sephadex column 
using salt and acid gradients for developing. A typical 
elution curve and the distribution of blood group activities 
are shown in Figure 17 Bovine and human type A stromata 
had similar elution patterns. 
Pooled fractions 1,2 and 3 of the front peak from 
SE-Sephadex column separation contained only proteins with 
lower than 6,000 molecular weight as determined by SDS gel 
electrophoresis. Proteins with larger molecular weights, 
especially hemoglobin, were found in fractions S and 6. The 
peak eluted with 90% formic acid, fractions 8 and 9, 
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100. 
contained predominantly larger molecular weight proteins in 
addition to residual amounts of smaller proteins. Ai~ounts 
of blood group activity found in the fractions did not 
follow the optical absorption curve. Table 11 summarizes 
the carbohydrate content and the capacity to inhibit anti-B 
and anti-I antisera in the pooled fractions. A similar 
distribution of A blood group activity was obtained from 
type A,I stroma. Fractions 1,2,3 contained most of the I 
activity. The A or B activity was four to eight times 
lower. The relative amount of I activity was lower in 
fractions 4,5 and 7. This was particularly noticeable in 
fraction 7 which lacked the capacity to inhibit anti-I cold 
agglutinins. Fraction 9 contained an unusually high amount 
of carbohydrate in this illustrated separation. This was 
due to a slower than usual flowrate which resulted in a 
breakdown of SE-Sephadex resin in 90"/o formic acid. This 
explains the low specific blood group activity. With the 
exception of 6, all pooled fractions contained varying 
amounts of lipid. 
Fraction 2 was further studied because it contained the 
highest specific I-inhibition capacity. Figurel8shows the 
results of SDS gel electrophoresis and the fingerprint 
after digestion with subtilisin. Thirty percent of the 
digested sample was recovered in the lipid fraction with 
Rf 0.8-1.0 following chromatography. Both the hydrophobic 
and the hydrophilic fractions with Rf 0.0-0.2 were tested 
for the anti-A, anti-B and anti-I inhibition capacity. 
101. 
Table 11 Analysis of poo l ed fractions from SE-Sephadex 
chromatography of human adult B, I stroma. 
Pooled Dry weight Percent Specific inhibition 
fractions carbohydrate capacity, inhibi tion 
units/mg carbohydrate 
anti-B anti- I 
1. 70 mg 5.9% 1,700 6,800 
2 . 100 mg 4.9% 2,400 19,400 
3 . 95 mg 4.9% 2,000 16 , 400 
4 . 22 mg 5.1% 1,500 1,000 
5. 7 mg 3.3% 1,500 3,300 
6. 40 mg 2. 8°ft, 
7. 22 mg 3.7% 2,600 
8. 15 mg 4.5% 
9 . 450 mg 38.4% 100 . 100 . 
100 ml of human adult stromata was fractionated on 
SE-Sephadex. The elution profile is given in Figure 17 
Carbohydrate was determined using the anthrone method. 
Specific inhibition capacity was calculated as outlined in 
Materials and Methods section . Nonspecific inhibition of 
anti-A serum was subtracted . 
The specific inhibition per mg of protein was not determined in 
this fractionation. In separate column fractions the blood group activity 
fa i led to correlate with the optical absorption curve, indicating that 
some of the blood group activity is not related to the protein concentration 
of the fraction. 
102, 
SDS gel electrophoresis of pool e d fr a ction 2 from SE-S ephadex column, 
Fraction 2 
Sta nda rds 
. I l:· 
lnSU lll 
I 
heavy cha ins of IgG origin G 
e 
Origin 
Phenol Red 
Figure 18. SDS gel electrophoresis of pool e d fr a ction 2 from SE-
Sephade x column s e paration of human adult stroma ta, and 
its fingerprint after subtilisin digestion, 
103. 
Only the hydrophilic fraction had A or B and I blood group 
activity. Nonspecific inhibition in the lipid fraction 
was too high to establish the presence of antigens. The 
hydrophilic fraction was free of positively charged peptides, 
as determined by paper electrophoresis at pH 1.7 . The 
only region with blood group activity was ninhydrin negative 
and peptide bond stain positive. 
After water elution the sample was further separated 
on Biogel P-6 column. The results are shown in Figurel9 • 
Only the excluded peak with larger than 6,000 molecular 
weight components had both A or B and I blood group activity. 
A second peak with molecular weight between 3-5,000 had only 
A or B but no I activity. Most of the carbohydrate was 
found in the excluded peak, but subsequent fractions con-
tained decreasing amounts. The specific anti-B inhibition 
in fraction 13 was 7-9,000 and in fraction 19 4-6,000 
inhibition units per mg of hexose. These values are approxi-
mately three times higher than the specific inhibition 
values of SE-Sephadex fractions. Anti-I inhibition was 
somewhat lower -- 9,000 inhibition units per mg of hexose 
instead of 19,000. Amino terminal analysis of the excluded 
fraction with dansyl chloride revealed Ser as the main N-
terminal amino acid, with minor amounts of Asp and Glu as 
possible contaminants. The amino acid analysis of the 
pooled fractions and the composition of a typical "mini-
protein" preparation from human red blood cell membranes are 
summarized in Table 12 • Fraction 11 was high in Ser and 
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Figure 19 
Human B,I adult stromata were fractionated on SE-
Sephadex. Fraction 2 from the front peak was subtilisin-
digested and chromatographed. Material with Rf 0.0-0.2 
was eluted with water and 1.0 mg was fractionated on P-6 
biogel column (1.2 x 27 cm) in 0.05 N NH 4Hco 3 • Samples 
were analysed by the anthrone method for carbohydrates. 
Blood group activity was located by agglutination inhibition 
assay, using 25 microliters of antisera with 2+ agglutina-
tion strength, and 1/3 of the lyophilized fractions which 
had been redissolved in 25 microliters of buffered saline~ 
106. 
Table 12 • Amino acid composition of Biogel P-6 column 
fractions. 
Amino 
acids 
nmoles per samples: 
fraction 11 fraction 17-18 fraction 23-29 miniproteins 
from human * 
rbc stromata 
CSA 
ASP 
THR 
SER 
GLU 
PRO 
GLY 
ALA 
CYS 
VAL 
MET 
ILE 
LEU 
TYR 
PHE 
TRP 
1.20 
6.68 
12.1 
12.7 
9.85 
4.10 
4.16 
5.53 
0.82 
5.47 
0.48 
1.89 
3.35 
2.19 
1.19 
LYS 2.35 
f\RG 6.09 
HEX-NH 2 19.34 
HEXOSE# 39.0 
3.58 
1.86 
2.48 
3.78 
2.03 
1.94 
1.80 
0.56 
2.05 
0.53 
0.30 
1.60 
0.05 
2.07 
3.0 
1.34 
3.87 
2.31 
3.22 
5.36 
1.52 
4.24 
3.18 
1.21 
2.07 
0.38 
1.31 
4.56 
0.89 
1.40 
1.87 
1.86 
2.85 
4.2 
4.26 
5.67 
5.42 
8.40 
7.11 
5.44 
4.17 
6.22 
1.02 
3.60 
6.10 
2.16 
1.86 
3.32 
2.53 
n.d. 
n.d. 
* = unpublished data from Dr.T.Laico, Dr. E.Ruoslahti, Dr. 
W. Dreyer. # = determined by anthrone method. n.d. = 
not determined. -- = none detected. 
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Thr, as was the sample prepared from the hydrophilic frac-
tion of the subtilisin digested whole stroma . The hexos-
amine content was higher in this fraction than in others, 
with a ratio of total hexose to hexosamine of 2 . Subsequent 
fractions showed marked differences in amino acid composition; 
the amounts of Ser and Thr were always lower then Asp and 
Glu. 
Fractions were treated with pronase in order to find 
out if complete degradation of peptides had any effect on 
the inhibition capacity. The results, summarized in Table 
13, show that the I activity was completely destroyed by 
· pronase, without any significant change in A or B blood 
group activity. 
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Table 13. The effect of pronase treatment on the blood 
group activity in factions from Biogel P-6 
column separation. 
Fraction 13 Dilution of the samples 
1/2 1/4 1/8 1/16 1/32 1/64 
Anti-B serum 
Untreated sample + + 2+ 
Pronase treated + + 2+ 
Anti-I (HOV) serum 
untreated sample + 2+ 2+ 
Pronase treated + 2+ 2+ 2+ 2+ 2+ 
Fraction 19 
Anti-B serum 
Untreated sample 2+ 2+ 2+ 2+ 
Pronase treated 2+ 2+ 2+ 2+ 
Anti-I (HOV) serum 
Untreated sample 2+ 2+ 2+ 2+ 2+ 2+ 
Pronase treated 2+ 2+ 2+ 2+ 2+ 2+ 
Samples were digested with pronase(3% by protein weight) for 
30 minutes at 37°C; mixed with an equal volume of anti-I 
sera diluted with 20% bovine serum albumin to an agglutina-
tion strength of 2+. The agglutination inhibition assay 
was carried out at 4°C; adult,I red blood cells in 200/o 
bovine serum albumin were used to test for the anti-I cold 
agglutinins. 
DISCUSSION 
One advantage in studying the I-antigen system in man 
is the availability of well defined, easily purifiable cold 
agglutinin with anti-I-specificity. These IgM molecules have 
restricted heterogeneity, and their molecular structures can 
be studied by standard methods of protein chemistryo 
The cold agglutinins studied have exhibited a wide 
range of thermal amplitudes as indicated in Figure 4. The 
normal anti-I isoagglutinin present in the serum of DAZ was 
active at 37°c, and no increase in agglutination titer was 
found at lower temperatures. This is in accord with previous 
observations that only agglutinins synthesized in response 
to microbial infections are cold acting. The agglutination 
characters of the sera from COH and AB3 well demonstrated 
the results of viral influenza or infections by other agents 
responsible for pneumonia. 
These well-characterized protein molecules are now 
available to study the development of the I-antigen in post-
natal infants and the status of this antigen in patients with 
hemolytic anemias~ The IgM molecules offer an additional 
advantage in their multiple binding sites. In order to bind 
to a cell surf ace sufficiently strongly to produce aggluti-
nation, these agglutinins must attach to more than one antigen-
ic site on the same surface. This requirement for having 
in the vicinity more than one antigenic site with blood 
uo 
group specificity automatically makes the anti-I reagents 
also sensitive to the site distribution on the cell surf ace. 
The importance of the two-dimensional distribution of 
molecules on the membrane surf ace has been recognized by 
numerous investigators. Recent experiments, for example, 
by Linscott (91) indicate that the density. of antigenic 
determinants on a cell has a profound effect on the hemolytic 
efficiency of the complement system. This work suggests that 
the affinity with which IgM molecules bind the c1 component 
of the complement system is proportional to the number of 
antibody combining sites occupied by the antigen. Low anti-
gen density on the surface results in reduced c1 fixation. 
Hoyer and Trabold (92) have Qeveloped a model passive 
hemagglutination system, using red cells coupled with sulf an-
ilic acid groups to study the importance of antigen site 
densityo Relative site numbers were estimated from the 
covalently linked s 35-sulfanilic acid and the "effective" 
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antigen site numbers were determined with I -labeled 
rabbit IgG anti-sulfanilic acid. Cells which had fewer than 
20,000 antigen sites per cell were not agglutinated. The 
agglutination titers of purified IgM antibody were 10-20 
times greater than those of IgG antibody when preparations 
with the same protein concentrations were compared. These 
findings emphasize the need to consider differences in 
antigen site density when comparing blood group systemso 
The type of antibody molecule must also be taken into consid-
eration, because of the differences between IgG and IgM. 
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In the I blood group system cells with less then 20,000 
antigen sites would be typed as I-negative. This does not 
mean that molecules with I-specificity are not expressed on 
the surf ace, but only implies a low-density distribution. 
The changes from the phenotype i cord to the I-adult have 
to be viewed in this molecular perspective. 
The presence of anti-I isoagglutinins in the fetus with 
I-positive genotype presumably represents no danger to the 
individual as long as the cell surf ace is low in antigen 
sites. The rapid erythropoietic proliferation during late 
embryological development might be responsible for the low 
distribution. The presence of incomplete oligosaccharide 
chains on the cell surf ace explains the exvression of H-
specif ici ty on cord cells of a group A individual. IgM 
with anti-A specificity in an A2 type individual represents 
an analogous situation. The low density of antigen distri-
bution could however, be the result of some additional differ-
ences in the molecular structure of some membrane structural 
component. An example would be having two different carrier 
molecules for the oligosaccharide side c~ains. The A2 indi-
vidual would have the capacity to attach sugars to only one 
of the carrier molecules, while an A1 individual could com-
plete both molecular structures. The findings of Hakomori 
et al. (14) are in agreement with such an hypothesis. 
Are the embryonic antigens related to unfinished mole-
cules exposed to the cell surf ace? It is possible that some 
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serologically determined embryonic specificities could 
be explained by such a molecular interpretation. 
The enzymes responsible for the biosynthesis of mole-
cules exposed on the surf ace appear to be regulated by a 
different molecular mechanism than the one responsible for 
the regulation of the hemoglobin subunit synthesis. This 
conclusion is drawn from the study of the correlation 
between the appearance of adult hemoglobin and the expression 
of the I-agglutinability. The rate of synthesis of mole-
cules responsible for the I-specificity was not closely asso-
ciated with the rate of beta polypeptide chain synthesis in 
postnatal inf ants. Although the two events take place at 
approximately the same time in development, such wide varia-
tion is found in the percentage of HbF in the"I-negative" 
cell population that one has to rule out a regulatory mechan-
ism which would exercise full and direct control over both 
developmental changes. The single-cell studies provided 
additional evidence. Cells which appear as "I negative" on 
their surface can have predominantly adult hemoglobin content. 
The pooled cell studies also demonstrated that cells with 
sufficient I-specific molecules on their surf ace to appear 
as the 'adult-like' phenotype can contain considerable amounts 
of fetal hemoglobin. These findings are in agreement with 
the previous observations on erythrocytes from patients with 
persistent fetal hemoglobin disease. In these individuals 
the genetic locus for the structure of beta polypeptide chain 
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remains depressed and the synthesis of a gamma chain per-
sists throughout life. So far there has been no ev i dence 
reported that such a condition has any effect on the bio-
synthesis of cell-surface-related mo l ecules. There indivi-
duals' erythrocytes type serologically as normal "I-positive". 
However, because exact molecular fractionation of membrane-
specific molecules and their precise quantitation has not 
yet been achieved, one ·has to accept this information with 
some caution. 
The rate of A antigen expression on the erythrocytes 
from postnatal infants seems to be related to the rate of 
I antigen expression. This was demonstrated by the quantita-
tion of A antigenic sites on "I-negative" and "I-positive" 
cells, using labeled anti-A antibody molecules. 
The site of erythropoiesis may have a significant role 
in regulating the type of hemoglobin synthesis . Such a rela-
tionship could be best studied in mice, where there are indi-
cations that the type of hemoglobin synthesized is dependent 
on the erthropoietic site {93) . Is the I-antigen exclusive 
to the bone marrow-derived erythrocytes in humans? It is 
difficult to answer this question without molecular fraction-
ation of erythrocyte membranes from an embryo of 5-6 months 
of age. Serological tests would only tell if the I-antigen 
carrying molecules are available to the antibody population 
used for the tests . 
The results from the experiment in buf fy coat cell 
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membrane fractionation suggest that the I-specific mole-
cules are not present on the surf ace of cells derived from 
the lymphopoietic cell proliferation, or if they are present 
their amount is less than 5% of the red blood cell's. Anti-
gens expressed on the lymphocytes are not necessarily present 
on erythrocyte surfaces. Transplantation antigens are for 
example very difficult to detect on human red blood cells, 
and lymphocytes are not agglutinated by anti-A or anti-B 
sera. The presence of ABO antigens of lymphocytes has, 
however, been demonstrated by immunoabsorption methods (94). 
The molecules carrying the ABO specificity on the lymphocyte 
surface have not yet been characterized or isolated. 
There are indications that the lymphopoietic and 
erythropoietic proliferation originates from a common stem 
cell (66). An example of the kind of experiments used to 
prove this differentiation scheme has been described by 
Till et al. (95). Bone marrow cells with identifiable 
chromosomal markers are injected into irradiated mice. Stem 
cells present in the bone marrow are capable of repopulating 
the tissues of the immune and of the hernopoietic system. 
Questions arise with respect to the differentiation of this 
stern cell~ When and by what mechanism do certain specific 
events show an effect on the differentiating cell's surface? 
Is I-antigen agglutinability an exclusive property of the 
mature erythrocytes or does this surf ace specificity develop 
gradually during erythropoietic differentiation? Currently 
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there are no answers to these questions, but indirect observa-
tions suggest that the marrow transition time may play an 
important role in the expression of surface specificity. The 
I-antigen system may serve as an excellent tool to answer 
the question. Hi l lman and Gib l ett (2 8 ) h ave a lready reported 
that when there is a shortage of red blood cells, premature 
red cells are delivered into the circulation. This shorten-
ing of normal maturation is associated with an increase of 
i-activity. This observation may explain why patients with 
anemia due to a variety of disorders also have an elevated 
level of i-activity. Exact molecular quantitation of anti-
genic sites as a function of maturation time would be of 
utmost interest. 
The chemical and enzymatic alterations of human adult 
stromata revealed very little information on the possible 
molecular bases of I-antigenic specificity . The experiments 
that the specificity requires the integrity of carbohydrate 
molecules on the surf ace , and ruled out sialic acid as an 
integral part of the I specificity. Acetylation of free 
amino groups had no detectable effect on the antigen. 
Molecular fractionation of cell membranes and the local-
ization of fractions with blood group activity proved more 
promising. The success of any isolation approach depends on 
the detection methods available . In all these determinations 
one has to keep in mind that a lack of inhi bition of a blood 
group specific agglutination system does not prove that the 
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antigen~arrying molecular species are not present. Con-
versely, the inhibition of the agglutination does not 
necessarily prove the presence. The finding that insoluble 
aggregates could show blood group activity only following 
trypsin digestion illustrates the first point; the very 
high nonspecific inhibition by the hydrophobic fraction 
illustrates the second. In all experiments, careful con-
trols were included to assure reliable conclusions~ 
The first important observation in comparing erythro-
cyte membranes from adult and cord blood samples was the 
striking similarity between their tryptic fingerprints. 
Their similarity was also noted in the observations on 
subtilisin digested membrane samples. This suggests that 
the major protein components of the cells do not change 
much from birth to adult maturation. The second important 
observation was related to the quantitation of I-inhibition 
capacity by the adult and cord erythrocyte stromata. Both 
samples have approximately equal amounts of total carbohy-
drate and protein. However, the stromata prepared from 
adult I-positive erythrocytes absorbed 64-128 times more 
anti-I cold agglutinins than did the stromata prepared from 
cord red blood cells. After disruption of the membrane and 
separation of the hydrophilic components by paper chroma-
tography, the difference was only twofold. There are several 
possible explanations for this observation. The recovery of 
blood group activity could vary for the two samples, or the 
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distribution of the activity could be such that more adult 
I-specific molecules are present in the hydrophobic frac-
tion, in which their detection would be difficult because of 
the high nonspecific inhibition by this fraction . Another 
explanation could come from the hypothesis that the I-anti-
gen is present in larger quantities in the cord rbc membrane 
but it is not exposed to the surface, or it is covered up 
by other surface molecules. Another explanation would be on 
the basis that the display of the molecules responsible for 
the specificity is the critical factor in anti-I agglutinin 
absorption. This would mean that the two dimensional distri-
bution of the molecules is responsible for the difference of 
IgM binding capacity on the cell surface . Once this molecu-
lar pattern is disrupted the difference becomes less noticea-
ble and the specific inhibition of the two preparations may 
reflect only the number of molecules present in the membrane. 
The average distance between I-antigen sites on a cell sur-
face, assuming uniform distribution , was estimated to be 
80-100 °A. This distance is the same as the distance 
between the binding sites of the IgM macroglobulin molecules, 
as measured on electron micrographs . Parkhouse et al.(96) 
reported the overall diameter of IgM molecules to be 300-
375 °A. Each molecule consists of five Y-shaped subunits; 
the two arms of the subunits correspond to the Fab pieces 
with one binding site for each piece. The nearest binding 
sites are 70-80 °A apart. Cooperative binding would be 
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observed if such an IgM molecule were to approach a surf ace 
with an antigen distribution of 80-100 °A. A twofold 
decrease in antigen sites would have greater effect on IgM 
binding if the antigens are distributed on a surf ace in a 
regular molecular pattern rather than being randomly distri-
buted in a solution. Accordingly the binding of 7S IgG mole-
cules with only two binding sites would be less affected by 
such a molecular arrangement. No 7S anti-I IgG molecules 
have been detected so far; therefore it would be difficult 
to test the validity of this hypothesis. Antibodies direct-
ed against the A antigen system do however, confirm the 
relationship outlined with the I system. Anti-A 7S IgG 
molecules do not distinguish between the A2 and A1 subtypes 
as well as do the 19S IgM molecules (15). The IgM molecules 
agglutinate only the A1 cells with the higher antigen dens-
ity distribution. 
The fractionation of erythrocyte stromata produced 
several membrane fractions with blood group activity. It is 
important to note that all the fractions containing I-acti-
vity also had ABO activity, but not all the ABO activity-
containing fractions had I-activity. Part of the diffi-
culty in evaluating this observation i s rooted in the prob-
lem of antigen detection. I-activity was detected by inhi-
bition of an anti-I serum in which all of the specific anti-
bodies belong to the 19S IgM molecules with multiple binding 
sites, whereas the anti-A or B sera contain both IgG and IgM 
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antibody molecules. It may be i mport ant to observe that 
the major I-containing samp le after separation on SE-Sepha-
dex column was the so-calle d "miniprotein containing" frac-
tion. This fraction contains l ipid in addition. All of 
the protein molecules in this fraction , as determined with 
SDS gel-electrophoresis, were low molecular weight "mini-
proteins". The hydrophilic preparation from this fraction 
yielded a glycopeptide-containing sample which was further 
fractionated on a Bigel P-6 column. This separation reveal-
ed the presence of two different fractions , with different 
molecular weightso Only the larger molecular fraction con-
tained I-activity, but both had A or B activity. Pronase 
treatment destroyed I-inhibiting capacity of the larger 
molecular weight fraction but did not have any effect on the 
A or B activity in either fraction . Although these obser-
vations are in agreement with the possibility that the I 
specificity is located on a glycopeptide , and the integrity 
of the peptide portion is essential for the blood group 
specificity,interpretation must wait until possible contami-
nation by glycolipids is precisely investigated . The 
destruction of inhibition capacity by pronase treatment indi-
cates that the role of polypeptides may be as carrier mole-
cules, but does not prove it . The difference in pronase 
sensitivity could be explained by the variation in the detec-
ting antibody population. 198 IgM molecules are better 
inhibited by larger aggregates and therefor e the pronase 
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activity would be more noticeable in relation to the inhi-
bition capacity of the I antigen than to the ABO specifi-
city. Further purifications of these glycopeptides are in 
progress and will eventually reveal the molecular basis of 
the specificity. The amino acid composition of the larger 
hydrophilic molecular fraction is similar to the composition 
reported for the M, N blood group activity-carrying glyco-
peptides. 
In addit ion to the previous observations it is important to point 
out the nature of protein fractionation on SE- Sephadex column. In all 
separations performed, various amounts of so-called "miniproteins" were 
recovered in fractions lp3 and in fraction 9. The variations in specific 
blood group activity i ndicate that fractionation was achieved which behaved 
independently from the protein distribution. Although low specific activi t y 
per mg of hexose was found in fraction 9, the total amount of blood group 
activity was significant. Approximately 1 0% of the total I activity was 
recovered in this fraction and about l10% of the B activity. The amount of 
specific activity per mg of protein or per mg of lipid was not determined. 
The light chains purified from the cold agglutinin IgM molecules had 
only one amino acid residue in the first eleven N-terminal positions. '11his 
i ndicates a restricted heterogeneity and a possibl e monoclonal origin for 
the antibody molecules. Such findings have been previously reported by 
Cohen et al . (56) . The production of restricted antibody heterogeneity 
might be similar to the production of structurally homogeneous antibodies 
against capsular pol ysaccharides of pnewnococci (100). 
121. 
References. 
1. Libavius, A. (1615) Appendix necessarius syntagmatus 
ancarnorum chymicorum contra Henningum Sheunemannum. 
Frankfort. IV:8. 
2. Denys, J.(1667). Philos. Trans., £:489. 
3. Landsteiner, K. (1901). Wein. Klin. Wschr., 14:1132. 
4. Dungern, B. von, and Hirszfeld,L. (1911). z. Immun., 
.§:526. 
5. Race, R.R. and Sanger,R. (1968). Blood groups in Man. 
Blackwell Scientific Publications Ltd., F.A. Davis 
Company, Philadelphia, Pa. 
6. Bach, F.H. (1970). Science 168:1170. 
7. Watkins, W.M. (1966). Science, 152:172. 
8. Hearn, V.M., Smith, Z.G. and Watkins, W.M. (1968). 
Biochem. J. 109:315. 
9. Ziderman, D., Gompertz, s., Smith, Z.G. and Watkins, W.M. 
(1967). Biochem. Biophys. Res. Corcunun. 29:56. 
10. Levine, P., Robinson, R., Celano, M.J. Briggs, D. and 
Falkinburg, L. (1955). Blood 10:1100. 
11. Jamieson, G.A. and Greenwalt, T.Ju (1969). Red Cell 
Membrane; Structure and Function. Chapter 8 by 
Sweeley, c.c. and D~wson, G. J.B. Lippincott 
Company, Philadelphia and Toronto. 
12. Yamakawa, T., and Suzuki, S. (1951). J. Biochem. (Tokyo) 
38:199. 
13. Yamakawa, T., Nishimura, s., and Kamimura, M. (1965). 
Jap. J. Exp. Med. 35:201. 
14. Hakomori, s.r. and Strycharz, G.D. (1968). Biochemistry 
(Wash.) l: 1279. 
15. Makela,o., E. Ruoslahti and Ehnholm, c. (1969). J. of 
Ircununology, 102:763. 
16. Zahler, P. (1968). Vox Sang. 15:81. 
17. Westphal, o., Luderitz, o. and Bister, F. (1952) z. 
Naturforsch. 7b:l48. 
122. 
18. Springer, G.F., Fletcher, M.A. and Pawloskis, o. (1967). 
Protides of the Biological Fluids. pp. 109. 
Elsevier. 
19. Cook, G.M.W. and Eylar, E.H. (1965). Biochim. biophys. 
Acta 101:57. 
20. Whittemore, N.B., Trabold , NoC ., Reed, C.F., and Weed, 
R.I. (1969). Vox Sang. 17:289. 
21. Economidou, J., Hughes-Jones, N.C. and Gardner, B. (1967). 
Vox Sang. 12:321. 
22. Shimada, A., Yamana, Ko and Nathenson, S.G. (1970). 
Proc. Nat. Acad. Sci. (Wash.) 691. 
23. Weiner, A.s., Unger, L . J., Cohen, L.and Feldman, J.(1956). 
Ann. Intern. Med. 44:221. 
24. Marsh, W.L. (1961). Brit. J. Haemat. 2:200. 
25. Bingham, C.P. (1968). The Post natal development of the 
I and i antigens. Thesis submitted to the School 
of Hygiene and Public Health of the Johns Hopkins 
University. Baltimore, Maryland. 
26. Dacie, J.V. (1962). The Haemolytic Anaemias, Part II, 
2nd ed. New York, Grune and Stratton, Inc. 
27. Giblett, E.R., and Crookston, M.C. (1964). Nature, 
201:1138. 
28. Hillman, R.s., and Giblett, E.R. (1965). J. Clin Invest. 
44:1730. 
29. McGinness, M.H., Schmidt, P.J., and Carbone, P.P. 
(1964). Nature 202:606. 
30. Jenkins, W.J., Marsh, W.L., and Gold, E.R. (1965)0 
Nature 205:813. 
31. Ducos, J., Ruffie , J., Columbies, P., Marty, Yo and 
Ohayon,E. (1965). Nature 208:1329. 
32. Marcus, D.M., Kabat, E.A., Rosenfield, R.E., (1963). 
J. Exp. Med., 118:175. 
33. Yakulis, V., Costea, N. and Heller, P. (1965). P.S.E. 
B.M. 121:812. 
34. Tippett,P., Noades, J., Sanger,R., Race, R.R., Sausais, 
L., Holman, C.A. and Buttimer, R.J. (1960). Vox 
Sang • ..2,: 107. 
123. 
35. Marsh, W.L., Reid, M., and Nichols, M. (1965). Abstract 
presented a t the 22nd Annual Meeting of the Am. 
Ass. of Blood Banks. 
36. Jenkins, W.J., Marsh, W.L., Noades, J., Tippett, P., 
Sanger, R., and Race, R.R. (1960). Vox Sang .2,: 97. 
37. Olesen, H. (1966). Scand. J. Clin. Lab. Invest. 
18:1. 
38. Evans, R.s., Turner, E., and Bingham, M. (1965). Amer. 
J. Med. 38:378. 
39. Rosse, W.F., Dourmashkin, R., and Humphrey, J.H. (1966). 
J. Exp. Med., 123:969. 
40. Issitt,P.D., Tegoli, J., Jackson, v., Sanders, c.w. and 
Allen, F.H., Jr. (1968). Vox Sang. 14:1. 
41. Adinolfi, M. (1965). Immunology,2:43. 
42. Schmidt, P.J., Barile, M.F. and McGinniss, M. (1965). 
Nature,205:371. 
43. Altucci, P., Busnanno, G., Cocco, F., Devargas, F. and 
Varone, G.L. (1968). Acta Hocemat • .±Q:l34. 
44. Feizi, T. and Taylor-Robinson, D. (1967). Immunology, 
·lJ.:405. 
45. Feizi, T., Taylo~-Robinson, D., Shields, M.D., Carter, 
R.A. (1969). Nature,111_:1253. 
46. Costea, N., Yakulis, v. and Heller, P. (1965). Blood, 
1§.:323. 
47. Costea, N., Yakulis, v. and Heller, P. (1969). Contri-
bution No. 15. Proc. Am. Soc. Hemat. Philadelphia. 
48. Costea, N., Yakulis, v. and Heller, P. (1970). Blood 
]2: 583. 
49. Layrisse, z. and Layrisse, M. (1968). Vox Sang. 1~ :369. 
SO. Bloom, A.D., Neel, J.V., Choi, K.W., Iida, s. and Chagnon, 
N. (1970). Proc. Natl. Acad. Sci. (Wash.). 66:920. 
51. Booth, P.B., Jenkins, W.J. and Marsh, W.L. (1966). 
Brit. J. Haemat. 12:341. 
52u Miller, F. and Metzger, H. (1965). J. Biol. Chem. 
240:3325. 
124. 
53. Costea, N., Yakulis, V. and Heller, P. (1966). Science 
152:1520. 
54. Harboe, M., Van Furth , R., Schubothe, H., Lind, K. and 
Evans, R.s. (1965). Scand. J. Haemat. 2:259. 
55. Feizi, T. (1967). Science, 156:111. 
56. Cohen, s. and Cooper, A.G. (1968). Immunology, 15:93. 
57. Reed, T.E. and Milkovich, L. (1968). Vox Sang. 14:9. 
58. Stormont, c., Julian, L.M. and Suzuki, Y. (1958). 
Transplantation Bulletin, 2:133. 
59 • . Owen, R.D. and Mallek, P. (1954). Biol. Ann. Report. No. 
84. California Institute of Technology. 
60. Sanders, B.G. (1968). J. Exp. Zoology, 167:165. 
61. Klein, J. (1964). Proc. of the European Animal Blood 
Group Conference. Prague. 
62. Gold, P. and Freedman, s. (1964) Transplantation 2:627. 
63. Boyse, E.A. and Old, L.J. (1969). Annual Review of 
Genetics, ].:269. 
64. Tatarinov, I.S., Assekritova, I.V., Masiukevich, V.N., 
Perova, S.D. (1967). Ter. Arkh. 39:8,43. 
65. Krupey, J., Gold, P. and Freedman, s.o. (1968). J. Exp. 
Med., 128:387. 
66. Ingram, V.M., McCulloch, E.A., Gowans, J.L., Granick, s. 
Levere, R. and Gordan, A.S. (1968). XII. Congress 
International Society of Hematology. New York. 
67. Betke, K. (1966). Proc. 11th Congr. Int. Soc. Blood. 
Trans£. Sydney. No. 29. p. 1085. 
68. Wintrobe, M. (1961). "Clinical Hematology", 5th ed. 
Lea and Febiger, Philadelphia. 
69. Kovach, J.S., Marks, P.A. Russell, E.s. and Epler, H. 
(1967). J. Mol. Biol. 12_:131. 
125. 
70. Harris, Harry. (1970). The Principles of Human Bio-
chemical Genetics. North-Holland/American Elsevier. 
71. Hyland Reference Manual of Immunohematology. Fourth 
edition, (1966). Hyland Laboratories, Los Angeles. 
72. Campbell, D.H., Garvey, J.S., Cremer , N.E. and Sussdorf, 
D.H. (1963). Methods in Immunology, W.A. Benjamin, 
Inc. New York. 
73. Mittal, K.K., Mickey, M.R., Singal, D.P. and Terasaki, 
P.I., (1968). Transplantation ..§.:913. 
74. Lamm, M.E. and Small, P.A., Jr. (1966). Biochemistry • 
.2_:267. 
75. Chaplin, H., Cohen, s. and Press, E.M. (1965). Biochem. 
J. 95:256. 
76. Kunkel, H. and Slaten, P. (1952). Proc. Soc. Exp. Biolo 
80:42. 
77. Edman, P. and Begg, G. (1967). European J. Biocheijt. 
£:80. 
78. Singer, K., Chernoff, A.I. and Singer, L. (1951). Blood, 
..§.:413. 
79. Jones, T.R. and Schroeder, W.A. (1963)0 J. Chrom. 10:421. 
80. Matioli, G., Brody, s. and Thorell, B. (1962) Acta 
Haemat. 28:73. 
81. Greenwood, F.c. and Hunter, W.M. (1963). Bioche~. Jo 
89;114. 
82. Lee, T. and Hager, L.P. (1970). Federation Proc. 29:599. 
83. Warren, L., Glick, M.c. and Nass, M.K. {1966). J. Cellu-
lar Physo 68:269. 
84. Tanner, M., Gray, W. and Dreyer, W.J. (1970) Manuscript 
in preparation. 
85. Laico, MoT., Ruoslahti, E.I., Papermaster, D.S. and 
Dreyer, W.J. (1970). Proc. Nat. Acad. Sci. (Wash.) 
Submitted for publication. 
86. Ruoslahti, E., Laico, M.T. and Dreyer, w.J. {1970) 
Manuscript in preparation. 
126. 
87. Katz, A.M., Dreyer, W.J. and Anfinser, C.B. (1959). 
J. Biol. Chem. 234:2897. 
88. Shapiro, A.L., Vinuela, E. and Maizel, j.v. (1967). 
Biochem. Biophy.s. Res. Corn . rn. Z.Q: 815. 
89. Rondle, c.,J.M. and Morgan, ·w.T.J. (1955) Biochem. J. 
61:586~ 
90. Dische, z. (1962). Methods in Carbohydrate Chemistry l: 
479. 
91. Linscott, W.D. (1970). J. of Immunology 104:1307. 
92. Hoyer, L.W. and Trabold, N.C. (1970). J. Clin. Invest. 
49:87. 
93. London, M.I., Tavill, A.s., Vanderhoff, G.A., Hunt, T. 
and Grayzel, A.I. (1967). Developmental Biology 
Supplement 1:227. 
94. Gurner, B.W. and Coombs, R.R.A. (1958). Vox Sang. ].:13. 
95. Till, J.E., McCulloch, E.A., Phillips, R.A. and 
Siminovitch, L. (1967). Cold Spring Harbor Symp. 
XXXI:C:461. 
96. Parkhouse, R.H.E., Askonas, B.A. and Dourmashkin, R.R. 
(1970). Immunology, 18:575. 
97. Sanders, B.G. and Wright, J.E. (1962). Ann. N.Y. Acad. 
Sci., 97:116 • . 
98. Betke~ K. and Kleihauer, E. {1958). Blut, 4:241. 
99. Gray, W.R., Dreyer, W. J. and Hood, L {1967). Science 155 :4165 
100. Jaton, J .c., Waterfield, M.D., Margolies, M.~. ·and 
Haber, E. (1970). Proc. Nat. Acad. Sci. (Wash.) 
66: 959 •. 

